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INTRODUCTION 
 
  
Objectives 
Objectives of this work: 
In this dissertation two novel technologies for the incorporation of proteins in a biodegradable 
drug delivery device for their controlled release are presented. In the first part of this thesis, 
electrospinning of emulsions composed of an organic polymer solution and an aqueous 
protein solution is illustrated as a versatile technique to generate protein loaded nanofiber 
nonwovens. After that, a new microencapsulation technique based on ionic liquids and 
biodegradable polymers is presented. With the recent progress in biotechnology and genetic 
engineering a large number of protein drugs have found therapeutic application. Futhermore, 
a prolonged delivery of bioactive proteins is also desirable for several biomedical applications 
like tissue engineering. In most cases these bioactive agents are rapidly degraded and 
deactivated. Due to their short biological half-lives, frequent administration is needed to 
achieve adequate concentrations for prolonged periods of time. Biodegradable delivery 
systems, such as nanofiber nonwovens or microparticles have proven their suitability as 
protein delivery devices for their use in biomedical applications.  
Chapter 1 gives an overview on the basic principles of the standard electrospinning process, 
the equipment needed and important process parameters. Several modifications of this 
technique are also discussed as well as the suitability of the resulting nanofibrous scaffolds for 
biomedical applications. 
For a successful preparation of protein loaded nanofiber nonwovens proper materials have to 
be selected. Several biodegradable polymers and the according suitable process parameters 
for the electrospinning of an emulsion of an aqueous cytochrome C solution in the respective 
polymer solution were investigated in Chapter 2. The resulting nanofiber nonwovens were 
characterized regarding their morphology and their protein release profile to determine the 
best candidate for subsequent studies.   
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In Chapter 3 electrospinning of emulsions composed of an organic poly(L-lactide) solution 
and an aqueous cytochrom C solution is described in detail. Different polymer concentrations 
and blending with hydrophilic polymers were illustrated and the effects on morphology and 
the protein release characteristics were demonstrated.  
A scaffold has to meet certain key requirements for its application in tissue engineering. 
Chapter 4 deals with the interactions of cells with nanofiber nonwovens composed of 
different polymers and polymer blends and clarifies whether the manufactured nanofibrous 
scaffolds met the requirements for a tissue engineering scaffold. 
An overview on microencapsulation focusing on phase separation and coacervation 
techniques is given in Chapter 5. The development of these techniques and its application in 
the pharmaceutical industry are elucidated. 
Ionic liquids are a new class of solvents with remarkable characteristics. Chapter 6 deals 
with the development of a new microencapsulation technique which uses an ionic liquid as 
one common solvent for a biodegradable polymer and a hydrophilic macromolecule. The 
solubilities of several biodegradable polymers and hydrophilic macromolecules in ionic 
liquids were determined and a suitable technique for the microencapsulation of bovine serum 
albumin and several dyes was developed. 
 
  
 
 
 
 
 
 
Chapter 1: 
 
A short overview on electrospinning of 
nanofiber nonwovens for biomedical 
applications 
 
  
 
Electrospinning of nanofiber nonwovens for biomedical applications 
Electrospinning is a term used to describe a class of fiber forming processes by which 
electrostatic forces are employed to control the production of fibers. It is a unique technology 
for the production of nanofiber nonwovens with fiber diameters ranging from tens of 
nanometers to microns, a size range that is otherwise difficult to access by conventional non-
woven fiber fabrication techniques [1-3]. Electrospinning first appeared in the patent literature 
in 1902 [4], but the technology did not receive notable attention (apart from the studies by 
Baumgarten [5] and Larrondo [6-8]) until the 1990s when Reneker and co-workers described 
electrospinning as a technique for the production of small diameter, continuous filaments [3, 
9, 10].  
Electrospun nanofiber scaffolds possess high surface-to-volume ratios, adjustable porosities 
and can be produced in a wide variety of sizes and shapes. In addition, the scaffold 
composition can be controlled to achieve desired properties and functionality. Due to these 
advantages, electrospun nanofibrous scaffolds were widely investigated in the past  years with 
materials of different compositions [11-15], for various applications, such as filtration [16-
18], optical and chemical sensors [19-24] and tissue engineering [25-28]. 
On a laboratory scale, electrospinning is a simple method to generate nanoscale fibers. Figure 
1 shows schematically an electrospinning system, which usually consists of three 
components: a high voltage supply, a spinneret (usually a metallic capillary) and a grounded 
collecting plate (usually a metal plate or a rotating drum) [29]. The spinneret acts 
simultaneously as an electrode, to which high voltage of 10 – 30 kV is applied. The collecting 
plate acts as a counter electrode with a distance between the two electrodes of ca. 10 – 25 cm. 
The amperage during electrospinning ranges from a few hundred nanoamperes to 
microamperes.  
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Figure 1: Basic electrospinning instrumentation consisting of a high voltage supply,  
a spinneret and a grounded collecting plate. 
 
When a polymer solution or melt is fed through the spinneret the electric field leads to a 
conical deformation of the droplet shape, which is designated “Taylor cone” after the 
pioneering work of Sir Geoffrey Ingram Taylor in 1964 [30]. He theoretically derived, that 
the perfect cone under such conditions has an angle of 98.6°. Beyond a critical charge density, 
the electrostatic repulsion of the charges overcomes the surface tension of the droplet, the 
cone becomes unstable and a jet of fluid is emitted from the apex of the cone. Figure 2 shows 
the conical deformation of a droplet in an electrical field [31].  
 
Figure 2: Deformation of a droplet in an electric field with increasing field strength 
 leading to the formation of the so called “Taylor cone”. 
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During the jet propagation towards the counter electrode the solvent in the jet stream 
evaporates and the fiber solidifies. As it does so, the filament is accelerated, stretched and 
may experiences a number of instabilities. In principle, the cone-jet operation is sufficient to 
draw out continuous fibers of small diameters by electrospinning. However in practice, as the 
jet thins, it usually undergoes one or more fluid instabilities which distort the jet as they grow. 
Although splaying of the jet was proposed in the 1990’s as the primary mode of instability 
[9], such events are relatively rare. The most common mode of instability in electrospun jets 
appear to be the growth of lateral excursions of the jet, the so called whipping instabilities 
[32-36]. 
 
Figure 3: Jet instabilities during electrospinning (A: real time image, B: high speed image) 
 
Figure 3 illustrates the instability region of a liquid jet electrospun from an aqueous solution 
of poly(ethylene oxide). The first picture resembles the view of the jet in real time, 
demonstrating that the jet at first followed a direct path to the counter electrode and 
subsequently became instable. It appears that the cone-shaped instability region is composed 
of multiple jets. However, the second picture shows a high speed photograph of the jet, which 
proves that the conical envelope contained only a single, rapidly bending or whipping thread. 
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These bending instabilities are mainly caused by electrostatic interactions between surface 
charges on the jet and the electric field and are the main reason for the high stretching rates 
which can be achieved by electrospinning [34, 36]. 
The resulting product is a nonwoven fibrous scaffold with a large surface area-to-volume ratio 
and small pore sizes. Fiber diameter and morphology can be controlled by many parameters, 
such as solution properties (viscosity, elasticity, conductivity and surface tension), electric 
field strength, distance between the spinneret and the collecting plate, temperature and 
humidity [37]. Due to the small fiber diameters, the yield per spinneret of the electrospinning 
process is extremely low. Recently, multi-jet electrospinning (Figure 4a) [38-40], blowing 
assisted electrospinning [41] and needleless upward electrospinning technologies (Figure 4b) 
[42] were developed, demonstrating the production capability for fabricating nanofibrous 
scaffolds in an industrially relevant scale. 
a 
 
b 
Figure 4: New technologies for the preparation of nanofiber nonwovens in an industrially relevant scale. 
(a: multi-jet electrospinning, b: needleless upward electrospinning) 
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The use of electrospun nanofibrous scaffolds for biomedical applications has attracted a great 
deal of attention in the past several years. Nanofibrous scaffolds have demonstrated their 
suitability as tissue engineering scaffolds [43-49], immobilized enzymes and catalysts [50-
57], as wound dressings [14, 58-63] and artificial blood vessels [64-68]. They have also been 
used as barriers for the prevention of post-operative induced adhesion [69-71] and vehicles 
for drug delivery [72-78]. For a successful application the nanofibrous scaffold has to exhibit 
suitable physical and biological properties closely matching the desired requirements. For 
example, in tissue engineering, the electrospun scaffold should physically resemble the 
nanofibrous features of the extracellular matrix (ECM) with suitable mechanical properties. It 
should also promote cell adhesion, spreading and proliferation. For a wound dressing, the 
nanofibrous scaffold should not only serve as a substrate for tissue regeneration, but could 
also deliver bioactive agents or antibiotic drugs in a controlled manner during the healing 
process.  
Physical and biological properties of electrospun nanofibrous scaffolds for biomedical 
applications such as hydrophilicity, mechanical modulus and strength, biodegradability, 
biocompatibility and specific cell interactions are largely determined by the materials’ 
chemical composition. Based on polymer physics, copolymerization and polymer blending 
are two effective means to combine different polymers to yield new materials properties. 
Thus, by selecting a combination of proper components and by adjusting the components 
ratio, properties of electrospun scaffolds can be tailored to the desired functions. For example, 
many kinds of copolymers [79-84] and polymer mixtures [85-95] were electrospun for 
biomedical applications with varying degrees of success. 
Many biopolymers like proteins, polysaccharides, DNA and lipids were also electrospun into 
fibrous scaffolds. Protein fibers, especially composed of collagen, gelatin, elastin and silk 
fibroin, were intensively studied in recent years [14, 64, 96-105]. Electrospun collagen 
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nanofiber scaffolds are particularly interesting for tissue engineering applications, since 
collagen is the principal structural element of the extracellular matrix in tissues. In the 
biopolymer class of polysaccharides dextran, chitosan and cellulose acetate were successfully 
electrospun into nanofibrous scaffolds. Electrospinning of aqueous hyaluronic acid solutions 
was also possible via a “blowing-assisted” electrospinning process [41]. These solutions had 
to be electrospun with the assistance of air flow at elevated temperatures. Nanofiber 
nonwovens composed of hyaluronic acid with a suitable degree of post-crosslinking are 
suitable scaffolds for cartilage repair, since hyaluronan is an abundant polysaccharide found 
almost exclusively in articular joints. Apart from proteins and polysaccharides, calf thymus 
DNA in an aqueous solution was electrospun to form nanofibers with diameters ranging from 
30 – 80 nm [106, 107]. However, no specific biomedical applications of such DNA 
nanofibers have been reported. Recently, McKee et al. reported nonwoven membranes 
electrospun from lecithin solutions in a single processing step [108]. 
Besides taking advantage of the materials compositions, the fabrication process, through 
which the fiber diameter, morphology and scaffold porosity can be manipulated, also plays an 
important role on the scaffold properties and functionality. Several innovative electrospinning 
techniques can enhance the functions and properties of electrospun nanofibers.  
Since the velocity of the fiber jet near the counter electrode is very high, the nanofibers are 
usually collected in a random fashion yielding nanofiber nonwovens. However, several fiber 
collection methods were described to obtain aligned nanofibers. Probably the most common 
technique relies on a rapidly rotating cylindrical collector, which either serves as counter 
electrode or is combined with an electrode [109-112]. Parallel fibers can also be produced 
with special electrode arrangements [113, 114]. The application of orientated electrospun 
scaffolds in the biomedical field was demonstrated in several studies. Xu et al. [68] 
investigated an aligned nanofibrous scaffold and found that human coronary artery smooth 
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muscle cells attached and migrated along the axis of the aligned nanofibers. They also found 
that adhesion and proliferation rate of the cells on the nanofibrous scaffold were significantly 
improved compared to those on a solid polymer film. 
The fabrication of core-shell nanofibers by coaxial electrospinning was first  reported by Sun 
et al. [115]. This technology provided the possibility to co-electrospin polymer solutions, 
which where difficult to process in a standard electrospinning process, yielding an ultrafine 
core within the shell of other polymeric materials (Figure 5). Furthermore, the coaxial 
electrospinning process provided a new pathway to incorporate drugs inside a fiber core, 
yielding nanofibers which were able to release the drugs in a controlled manner over a 
prolonged period of time [73, 116-120]. 
 
Figure 5: Principle of coaxial electrospinning and the resulting core-shell fibers. 
 
In contrast to coaxial electrospinning, where two different solutions are electrospun without 
direct mixing, two phase electrospinning describes electrospinning of two immiscible 
solutions as an emulsion [121-125].  The two-phase electrospinning process, using a single 
spinneret, provides the possibility to incorporate small molecules and/or macromolecules, 
including drugs and proteins in the nanofibrous scaffolds. The encapsulated bioactive 
molecules can be immobilized for a long time and afterwards released in a controlled manner.  
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Conclusion: 
Electrospun nanofibrous scaffolds demonstrated great potential for many biomedical 
applications. The concept of two-phase electrospinning offers the possibility of incorporating 
hydrophilic macromolecules in biodegradable nanofiber nonwovens for their controlled 
release. Due to its simplicity, this technique may offer potentially useful advantages over 
other electrospinning techniques in the applications of drug delivery and tissue engineering. A 
successful creation of nanofiber nonwovens has to start with the proper selection of materials. 
Chapter 2 will describe suitability studies of several biodegradable polymers for the 
fabrication of protein loaded nanofiber nonwovens. After a suitable candidate has been 
selected, mixtures of this biodegradable polymer with other polymers might be a useful 
approach to adjust the properties of the nanofiber nonwoven. This topic will be elucidated in 
Chapter 3. Whether the prepared drug delivery devices are suitable tissue engineering 
scaffolds will be demonstrated in Chapter 4 by investigating the interactions of a model cell 
line with the prepared nanofiber nonwovens. 
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Summary: 
Several biodegradable polymers (Poly(L-lactide) (PLLA) Resomer L210, poly(D,L-lactide-
co-glycolide) (PLGA) Resomer RG858 and  Poly(ethylene carbonate) (PEC)) were 
investigated for their suitability as biomaterials for the electrospinning of emulsions. Suitable 
process parameters were determined empirically and the resulting nanofiber nonwovens 
(NNs) were examined regarding their morphology before and after incubation in buffer 
solutions and regarding their protein release profile. PEC formed the most uniform fibers with 
diameters of 1 – 5 µm. PLLA and PLGA formed less uniform fibers but with smaller 
diameters of 0.3 to 1 µm. PEC and PLGA NNs showed only burst release of the incorporated 
protein and no further release within 2 weeks. PLLA fiber released the protein very slowly 
and in a controlled manner. Due to swelling PLGA and PEC NNs showed tremendous 
changes in morphology after the release study. The morphology of PLLA NNs was more or 
less unchanged after the release study. 
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Introduction: 
Polymeric drug delivery devices have numerous advantages compared to conventional dosage 
forms, such as improved therapeutic effect, reduced toxicity and convenience. However, the 
conventional polymeric drug delivery systems like nano- or microspheres, liposomes and 
hydrogels often exhibit the problem of a high burst release at the beginning. Electrospinning 
is a versatile technique for the generation of drug loaded polymeric nanofiber nonwovens for 
the controlled release of the incorporated drugs [1-6]. During the electrospinning process a 
strong electrostatic field is applied to a polymer solution held in a syringe with a capillary 
metal outlet. A pendant droplet of the polymer solution from the capillary outlet is deformed 
into a Taylor cone by the electrostatic field [7]. When the voltage surpasses a threshold value, 
the electric force overcomes the surface tension of the droplet and a charged jet of the solution 
is ejected from the apex of the Taylor cone [8, 9]. The fibers are collected as a nonwoven mat 
on an electrically grounded target. 
Encapsulation of low molecular weight drug substances like tetracycline hydrochloride [10], 
ibuprofen [11], rifampicin [12], and other molecules into electrospun NNs was already 
demonstrated by a number of authors [6, 13-17]. In most cases the drug was dissolved or 
dispersed in the polymer solution and was encapsulated using a one phase electrospinning 
method. Only very few studies on the encapsulation and release of macromolecules like 
proteins have been published [18-21]. Encapsulation of higher molecular weight substances is 
more difficult, because the electrospinning of macromolecular dispersions is more 
challenging than electrospinning of homogenous polymer solutions. The concept of coaxial 
electrospinning led to core-shell structured fibers which proved their suitability as drug 
delivery devices for larger molecules, but special equipment is needed for these 
electrospinning techniques [22-24]. Another approach which has not been investigated very 
extensively until now is the electrospinning of emulsions [19, 21, 25, 26]. 
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The goal of this study was the evaluation of suitable polymers and process parameters for the 
generation of protein loaded nanofiber nonwovens by electrospinning of emulsions. Poly(L-
lactide) and poly(D,L-lactide-co-glycolide) were chosen for this study, since they are the most 
widely studied biomaterials for protein drug delivery. Futhermore, poly(ethylene carbonate) 
was investigated for its suitability, since this polymer has very promising properties for its 
application in drug delivery. Cytochrome C was used as a model compound for the 
encapsulation of proteins. Suitable process parameters for the electrospinning of W/O 
emulsions of those polymer solutions were determined empirically and the morphology and 
the release profiles of the resulting nonwovens were investigated. 
 
Materials and methods: 
Poly(L-lactide) (PLLA) Resomer L210 (inherent viscosity 3.3 – 4.3 dl/g) and poly(D,L-
lactide-co-glycolide) (PLGA) Resomer RG858 (inherent viscosity 1.3 – 1.7 dl/g) was 
purchased from Boehringer Ingelheim (Ingelheim, Germany). Poly(ethylene carbonate) (PEC, 
batch 96906) was synthesized and provided by Novartis Pharma AG (Basel, Switzerland). 
Cytochrome C from horse heart was obtained from Fluka Chemie GmbH (Buchs, Germany). 
All other reagents used were of analytical grade. 
 
Electrospinning 
Different emulsions were prepared in 5 ml syringes using an Ultra Turrax T25 running at 
20500 rpm for 1 minute. A setup published previously was used for electrospinning [27]. 
Electrospinning was carried out using a variable high-voltage power supply, which can 
produce voltages ranging from 0 to 55 kV. It consists of one positive power supply attached 
to a blunt steel needle and one negative power supply attached to the counter electrode.  The 
syringes containing the different emulsion were attached to the blunt needle and were put into 
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a syringe pump pushing 50 µl of the emulsions per minute through the blunt needle. A round 
steel plate with a diameter of 9 cm served as the counter electrode. It was covered with 
aluminium foil for the collection of the different fibers.  
Nanofiber nonwovens were prepared by emulsifying 0.5 ml of an aqueous solution of 
Cytochrome C (20 mg/ml) into 2 g of different polymer solutions in methylene chloride. A 
voltage of +19 kV was applied at the needle tip, and –1 kV was applied at the counter 
electrode, which was 20 cm from the needle tip. 
 
SEM imaging 
Fragments of the nanofiber nonwovens were sputtered with gold in an argon atmosphere 
(0.3 mPa) using a sputter coater S-150 (Edwards Kniese & Co. GmbH, Marburg, Germany). 
Sputtering was carried out for each sample at 18 mA 2 times for 1 minute and after that 2 
times for 2 minutes. Images were taken with an SEM S-510 at 25 kV accelerating voltage 
(Hitachi Ltd. Corporation, Tokyo, Japan) using the Digital Imaging Scanning System 
(Version 5.4.12.1) purchased from point electronic GmbH, Halle (Saale), Germany. Images 
were analyzed with the Digital Image Processing System (Version 2.6.13.0) purchased from 
point electronic GmbH, Halle (Saale), Germany.  
 
AFM imaging 
AFM pictures were recorded using a JPK NanoWizard™ (JPK Instruments, Berlin, Germany) 
in intermittent contact mode to prevent sample damage. Si3N4 tips attached to I-shaped 
cantilevers with a length of 125 µm were used. The cantilevers had a resonance frequency of 
160 kHz. The line scan speed was about 1 Hz. Images were obtained in trace direction for 
amplitude displaying pictures and in retrace direction for height pictures, with both signals 
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being recorded simultaneously. Images were recorded in the height, amplitude and phase 
mode. For data analysis, the producer’s software was used.  
 
Protein Stability 
Native Page gel electrophoresis experiments were carried out using a Pharmacia LKB PHAST 
system (Pharmacia Biosciences, Uppsala, Sweden) and PhastGel separation media for Native 
PAGE (Pharmacia Biosciences, Uppsala, Sweden). The different protein solutions were 
applied on the ready-to-use PhastGel 18-25 (Pharmacia Biosciences, Uppsala, Sweden) via a 
PhastSystem applicator comb. These special sample applicators ensured that identical 
volumes were put on the separation gel. PhastGel Native ready-to-use buffer strips were used 
for the separation process. After applying current, the proteins migrated through the gradient 
gel and were separated according to their size. A Coomassie staining was carried out for 
protein detection using PhastGel Blue R tablets.  
 
Loading 
Loading of PEC nanofiber nonwovens was determined by dissolution of the fibers in 
methylene chloride and extraction of the protein with water. Loading of PLLA and PLGA 
nanofiber nonwovens was determined by degrading parts of the nanofiber nonwovens in 1 ml 
of 1 N NaOH. The amount of incorporated Cytochrome C was calculating by measuring the 
adsorption of the resulting solution at 412 nm using a UV/Vis spectrophotometer UV-160 
(Shimadzu Corporation, Kyoto).  
 
Release profile 
Release studies were carried out in PBS buffer solution pH 7.4. Samples of the nanofiber 
nonwovens (2 cm x 2 cm) were put in 15 ml plastic tubes and 2 ml release medium was 
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added. The tubes were constantly moved at a speed of 30 rpm at 37°C. At certain time points 
200 µl of the release medium were removed and replaced with fresh buffer solution. The 
amount of released cytochrome C was determined via BCA assay. 50 µl of the samples were 
mixed with 170 µl BCA reagent (BCA assay kit, Pierce, Rockford IL, USA) in 96 well plates. 
After 18h at ambient temperature the absorption at 560 nm was measured using a plate reader. 
All measurements were carried out at least in triplicate.  
 
Statistical analysis 
All quantitative results were carried out at least in triplicate. Data is expressed as mean ± SD. 
Statistical analysis was carried out using an unpaired student’s t-test. A value of p < 0.05 was 
considered to be statistically significant. 
 
Results and discussions: 
The objective of this study was to evaluate the feasibility to generate biodegradable nanofiber 
nonwovens (NN) via electrospinning of emulsions for the controlled release of proteins. The 
most widely investigated class of biodegradable polymers with regard to toxicological and 
clinical data are aliphatic poly(ester)s consisting of lactic and glycolic acid. Their 
corresponding polymers, poly(lactide) (PLA), poly(glycolide) (PGA) and copolymer 
poly(lactic-co-glycolic acid) (PLGA) have found wide-spread commercial application as drug 
delivery devices. Poly(ethylene carbonate) (PEC) is a thermoelastic polymer of high-
molecular weight which biodegrades non-hydrolytically and exclusively by surface erosion 
[28-31]. These degradation characteristics make PEC especially useful as a polymer matrix 
delivery system for the controlled release of proteins. We chose three different polymers for 
the evaluation of their suitability to prepare protein loaded NNs via electrospinning of 
emulsions: PEC (provided by Novartis), PLGA (RG858) and PLLA (Resomer L210). 
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Electrospinning is a very complex process, which is influenced by many different factors like 
the properties of the polymer itself (e.g. molecular weight, molecular weight distribution, 
glass transition temperature, and soluibility) and its solution (e.g. viscosity, concentration, 
surface tension, electrical conductivity). Even relative humidity and ambient temperature can 
have a significant impact. For these reasons, it is hard to make general recommendations 
about the process parameters and they usually have to be determined empirically. The 
following process parameters or ranges thereof where found to be suitable for electrospinning 
of the emulsions of this study: The distance between needle tip and counter electrode was 
always 20 cm and the voltage ranged between 20 to 25 kV. The feed rate of the emulsions 
was kept constant at 3 ml/h. The viscosities of the different emulsions were quite similar and 
the viscosity of an emulsion with a 2% PLLA solution as organic phase was determined as an 
example using a rotary viscosimeter. The experiment demonstrated that the emulsion was a 
Newtonian fluid with a viscosity of 921 mPa  s.  
After suitable process parameters were determined, emulsions of different compositions were 
electrospun and the morphologies of the resulting NNs were analyzed via SEM imaging. The 
PEC fibers adhered very strongly to the aluminium foil, which was used for their collection. 
As a consequence, the NNs were highly stretched during removal from the aluminium foil. 
PEC is known for its very high stretching rates [32]. Figure 1 shows SEM images of PEC 
NNs on aluminium foil (a and b) and PEC NNs after removal from the aluminium foil (c and 
d). There were no visible changes in morphology after the removal. NNs consisting of PEC 
showed the most uniform fibers but also the largest fiber diameters ranging from 1 to 5 µm.  
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Figure 6: SEM images of PEC nanofiber nonwovens on aluminium foil (a and b) and after 
removal from the aluminium foil (c and d). 
 
 
We were also able to visualize PEC NNs using AFM microscopy. AFM images confirmed 
that the fiber diameters ranged from 1 to 5 µm and furthermore demonstrated the smooth and 
nonporous surface of the PEC fibers (Figure 2).  
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Figure 7: AFM images of PEC nanofiber nonwovens. 
 
PLGA NNs consisted of rather irregular fibers and some bigger structures, which looked like 
burst beads. These structures are most likely due to the formation of a polymeric skin on the 
liquid jet covering the droplets of the aqueous phase at first and then collapsing (Figure 3).  
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        a              b 
  
 
Figure 8: SEM images of PLGA nanofiber nonwovens. 
 
Depending on the concentration of polymeric solution these structures could also be found in 
PLLA NNs. Higher polymer concentrations in the organic phase led to more uniform fibers 
with bigger diameters and less burst bead structures (Figure 4). In summary, PLLA NNs 
showed the most promising morphology, since non-fibrous structures only occurred at lower 
polymer concentrations and even at higher concentrations fiber diameters where still in a 
nanometer scale. 
 
1% L210 1,5 % L210 2 % L210 2,5 % L210 3 % L210  
Figure 9: SEM images of PLLA nanofiber nonwovens. 
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Native page gel electrophoresis was used to check whether the electrospinning process would 
have a negative effect on the protein. Rather high concentrations of the protein had to be 
applied on the gel, to achieve a visible Coomassie staining. Nevertheless, there were no 
visible changes in retention time between native cytochrome C, a cytochrome C solution, 
which was kept at 37 °C for 2 days, and the cytochrome C released from PLLA NNs. These 
results proved that neither degradation nor aggregation of the protein occurred during 
electrospinning (Figure 5). Other groups have also shown that electrospun proteins are stable 
and retain their bioactivity [18, 20]. 
 
 1 2 3 4 5 6 7 8
Figure 10: Native page gel of cytochrome C solutions (lane 1,4: fresh CytC solution as reference, lane 2, 5, 7: 
CytC released from PLLA nanofiber nonwovens, lane 3, 6, 8: CytC solution kept at 37°C). 
 
The next objective of this study was to develop a method for the determination of the release 
profiles of the different NNs to evaluate their suitability as drug delivery devices for the 
controlled release of the protein. The NNs had to be cut in smaller pieces to ensure that every 
part releases comparable amounts of the protein at the same rate. This in turn led to the 
problem that the total amount of protein released per sample was rather low and the 
concentration was below the detection limit of UV/Vis spectroscopy. Thus we decided to 
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determine the amount of released protein via a BCA assay. Since this protein assay also gave 
rather low values, we validated it according to the ICH guidelines for the “Validation of 
analytical procedures”. The experiments demonstrated that the BCA assay is a suitable 
detection method with a calculated detection limit of 1 µg/ml and a quantification limit of 
3 µg/ml. 
After successful validation of the BCA assay as suitable determination method, release 
profiles of the different NNs were determined. Depending on their solubility differently 
concentrated polymer solutions were prepared and 0.5 ml of an aqueous Cytochrome C 
solution was emulsified in 2 g of these polymer solutions. The resulting emulsions were 
eletrospun using appropriate electrospinning parameters. Protein loading and encapsulation 
efficiency strongly depended on the stability of the emulsion. PEC solutions formed the least 
stable emulsions with water. A part of the aqueous phase separated itself from the emulsion 
and was floating on the surface by the end of the elctrospinning procedure. As a consequence 
encapsulation efficiencies for PEC NNs were rather low at approximately 50%.  
Electrospinning emulsions for PLGA NNs were more stable and yielded encapsulation 
efficiencies of 80 to 85%. Emulsions consisting of a PLLA solution and an aqueous solution 
were the most stable with encapsulation efficiencies of 90 to 99%. 
Figure 6 shows release profiles of the different NNs. PEC and PLGA NNs showed only a 
burst release and no further release of the protein. The amount of immediately released 
protein depended on the polymer concentration of the organic phase and was very high with 
values up to 50%. PLLA NNs showed no burst release and a rather slow prolonged released 
for the incorporated protein. The amount of released protein was almost identical for NNs 
prepared from 2% and 3% PLLA solutions. NNs electrospun from emulsions containing 1% 
PLLA showed a slightly increased release rate.  
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Figure 11: Protein release profiles of PLGA, PEC and PLLA nanofiber nonwovens. 
 
At the end of the release study the NNs were withdrawn from the buffer solution and their 
morphologies were determined again using scanning electron microscopy. Figure 7 shows 
PEC NNs (a and b) and PLGA NNs (c and d) before and after the release study. Water uptake 
 51
Chapter 2 
led to swelling of the fibers and most fibers had lost their individuality and were more or less 
coalesced to a porous film especially in the case of PEC.  
 
   a            b 
    
   c            d 
    
 
Figure 12: SEM images of nanofiber nonwovens (a: PLGA before release study, b: PLGA after release study; 
c: PLGA before release study, d: PLGA after release study) 
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PLLA fibers showed almost no sign of degradation or swelling at the end of the release study 
(Figure 8). Only at a low polymer concentration of 1% PLLA in the organic phase of the 
electrospinning emulsion, some fibers were coalesced. 
    a            b 
   
    c            d 
   
 
Figure 13: SEM images of nanofiber nonwovens (a: PLLA electrospun from 1% solution before release study, 
b: after release study; c: PLLA electrospun from 3% solution before release study, b: after release study) 
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In summary, PEC and PLGA NNs were not suitable for an application as protein delivery 
device, since they showed only a rather high burst release of the protein and no further 
release, which might be due to their morphological changes by swelling during the release 
study. PLLA NNs showed the most promising characteristics for their use as protein delivery 
devices. They are able to release the incorporated protein in a controlled manner for a longer 
period of time and due to their low swelling behavior their morphology was not affected 
during the release study. 
 
Conclusion: 
We demonstrated the feasibility to prepare protein loaded, biodegradable nanofiber 
nonwovens via electrospinning of emulsions. Suitable process parameters for the 
electrospinning of different polymers were successfully determined. PEC nanofiber 
nonwovens showed the most uniform fibers with the largest diameters of 1 – 5 µm. PLGA 
and PLLA fibers had diameters smaller than 1 µm depending on the polymer concentration in 
the organic phase. Lower polymer concentration also led to the formation of “burst bead” 
structures, which where formed by the formation of a polymeric skin on the liquid jet 
covering the droplets of the aqueous phase at first and subsequent collapsing. Native page gel 
electrophoresis proved that neither degradation nor aggregation of the protein occurred during 
electrospinning. Release studies demonstrated that only PLLA nanofiber nonwovens showed 
a prolonged release of the encapsulated protein. PEC and PLGA fibers showed high burst 
release of the protein and no further release within 2 weeks. SEM images demonstrated that 
PEC and PLGA fibers coalesced to porous films due to water uptake during incubation in 
buffer solutions. PLLA fibers showed almost no sign of degradation or swelling during the 
release study. In summary, nanofiber nonwovens composed of PLLA showed the highest 
potential as scaffolds for the controlled release of proteins. 
 
54 
Evaluation of suitable polymers and process parameters for electrospinning 
References: 
1. Goldberg, M., R. Langer, and X. Jia, Nanostructured materials for applications in 
drug delivery and tissue engineering. J. Biomater. Sci., Polym. Ed. FIELD Full 
Journal Title:Journal of Biomaterials Science, Polymer Edition, 2007. 18(3): p. 241-
268. 
2. Kenawy, E.-R., et al., Release of tetracycline hydrochloride from electrospun 
polymers. Polymer Preprints (American Chemical Society, Division of Polymer 
Chemistry), 2002. 43(1): p. 457-458. 
3. Kenawy, E.-R., et al., Controlled release of ketoprofen from electrospun poly(vinyl 
alcohol) nanofibers. Materials Science & Engineering, A: Structural Materials: 
Properties, Microstructure and Processing, 2007. A459(1-2): p. 390-396. 
4. Liu, H.A., et al., Controlled release of nitric oxide from electrospun biodegradable 
biocompatible fibers. PMSE Preprints, 2008. 98: p. 802-803. 
5. Chunder, A., et al., Fabrication of ultrathin polyelectrolyte fibers and their controlled 
release properties. Colloids and Surfaces, B: Biointerfaces, 2007. 58(2): p. 172-179. 
6. Kim, K., et al., Incorporation and controlled release of a hydrophilic antibiotic using 
poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. Journal of 
Controlled Release, 2004. 98(1): p. 47-56. 
7. Yarin, A.L., S. Koombhongse, and D.H. Reneker, Taylor cone and jetting from liquid 
droplets in electrospinning of nanofibers. Journal of Applied Physics, 2001. 90(9): p. 
4836-4846. 
8. Hohman, M.M., et al., Electrospinning and electrically forced jets. I. Stability theory. 
Physics of Fluids, 2001. 13(8): p. 2201-2220. 
9. Hohman, M.M., et al., Electrospinning and electrically forced jets. II. Applications. 
Physics of Fluids, 2001. 13(8): p. 2221-2236. 
 55
Chapter 2 
10. Kenawy el, R., et al., Release of tetracycline hydrochloride from electrospun 
poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. Journal of Controlled 
Release, 2002. 81(1-2): p. 57-64. 
11. Jiang, H., et al., Preparation and characterization of ibuprofen-loaded poly(lactide-
co-glycolide)/poly(ethylene glycol)-g-chitosan electrospun membranes. Journal of 
Biomaterials Science, Polymer Edition, 2004. 15(3): p. 279-296. 
12. Zeng, J., et al., Biodegradable electrospun fibers for drug delivery. Journal of 
Controlled Release, 2003. 92(3): p. 227-31. 
13. Cui, W., et al., Investigation of Drug Release and Matrix Degradation of Electrospun 
Poly(DL-lactide) Fibers with Paracetanol Inoculation. Biomacromolecules, 2006. 
7(5): p. 1623-1629. 
14. Huang, Z.-M., et al., Encapsulating drugs in biodegradable ultrafine fibers through 
co-axial electrospinning. Journal of Biomedical Materials Research, Part A, 2006. 
77A(1): p. 169-179. 
15. Nikkola, L., et al., Electrospun multifunctional diclofenac sodium releasing 
nanoscaffold. Journal of Nanoscience and Nanotechnology, 2006. 6(9/10): p. 3290-
3295. 
16. Piras, A.M., et al., Development of diclofenac sodium releasing bio-erodible 
polymeric nanomats. Journal of Nanoscience and Nanotechnology, 2006. 6(9/10): p. 
3310-3320. 
17. Xie, J. and C.-H. Wang, Electrospun Micro- and Nanofibers for Sustained Delivery of 
Paclitaxel to Treat C6 Glioma in Vitro. Pharmaceutical Research, 2006. 23(8): p. 
1817-1826. 
18. Chew, S.Y., et al., Sustained Release of Proteins from Electrospun Biodegradable 
Fibers. Biomacromolecules, 2005. 6(4): p. 2017-2024. 
 
56 
Evaluation of suitable polymers and process parameters for electrospinning 
19. Sanders, E.H., et al., Two-Phase Electrospinning from a Single Electrified Jet: 
Microencapsulation of Aqueous Reservoirs in Poly(ethylene-co-vinyl acetate) Fibers. 
Macromolecules, 2003. 36(11): p. 3803-3805. 
20. Zeng, J., et al., Poly(vinyl alcohol) Nanofibers by Electrospinning as a Protein 
Delivery System and the Retardation of Enzyme Release by Additional Polymer 
Coatings. Biomacromolecules, 2005. 6(3): p. 1484-1488. 
21. Qi, H., et al., Encapsulation of Drug Reservoirs in Fibers by Emulsion 
Electrospinning: Morphology Characterization and Preliminary Release Assessment. 
Biomacromolecules, 2006. 7(8): p. 2327-2330. 
22. Zhang, Y.Z., et al., Coaxial Electrospinning of (Fluorescein Isothiocyanate-
Conjugated Bovine Serum Albumin)-Encapsulated Poly(e-caprolactone) Nanofibers 
for Sustained Release. Biomacromolecules, 2006. 7(4): p. 1049-1057. 
23. Sun, Z., et al., Compound core-shell polymer nanofibers by co-electrospinning. 
Advanced Materials (Weinheim, Germany), 2003. 15(22): p. 1929-1932. 
24. Jiang, H., et al., A facile technique to prepare biodegradable coaxial electrospun 
nanofibers for controlled release of bioactive agents. Journal of Controlled Release, 
2005. 108(2-3): p. 237-243. 
25. Xu, X., et al., Preparation of core-sheath composite nanofibers by emulsion 
electrospinning. Macromolecular Rapid Communications, 2006. 27(19): p. 1637-
1642. 
26. Xu, X., et al., Ultrafine medicated fibers electrospun from W/O emulsions. Journal of 
Controlled Release, 2005. 108(1): p. 33-42. 
27. Bognitzki, M., et al., Polymer, metal, and hybrid nano- and mesotubes by coating of 
degradable polymer template fibers (Tuft-process). Polymeric Materials Science and 
Engineering, 2000. 82: p. 45-46. 
 57
Chapter 2 
 
58 
28. Stoll, G.H., et al., Poly(ethylene carbonate)s, part II: degradation mechanisms and 
parenteral delivery of bioactive agents. Journal of controlled release, 2001. 76(3): p. 
209-25. 
29. Dadsetan, M., et al., In vivo biocompatibility and biodegradation of poly(ethylene 
carbonate). Journal of Controlled Release, 2003. 93(3): p. 259-270. 
30. Acemoglu, M., et al., Poly(ethylene carbonate)s, part I: Syntheses and structural 
effects on biodegradation. Journal of Controlled Release, 1997. 49(2,3): p. 263-275. 
31. Acemoglu, M., et al., Polymeric matrices and their uses in pharmaceutical 
compositions. 1995, (Sandoz Ltd., Switz.; Sandoz-Erfindungen 
Verwaltungsgesellschaft Mbh). Application: WO. p. 71 pp. 
32. Unger, F., et al., Poly(ethylene carbonate): A thermoelastic and biodegradable 
biomaterial for drug eluting stent coatings? Journal of Controlled Release, 2007. 
117(3): p. 312-321. 
 
  
 
 
 
 
 
 
Chapter 3: 
 
Electrospun biodegradable nanofiber 
nonwovens for controlled release of proteins 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Published in Journal of Controlled Release (2008) 127(2): p. 180-187
 
  
 
Electrospun biodegradable nanofiber nonwovens for controlled release of proteins 
 
 
 
 
 
 
 
 
 
 
Summary 
Electrospinning of emulsions composed of an organic poly(L-lactide) solution and an aqueous 
protein solution yielded protein containing nanofiber nonwovens (NNs) having a mean fiber 
diameter of approximately 350 nm. Cytochrome C was chosen as a hydrophilic model protein 
compound for encapsulation. SEM imaging and gas adsorption measurements were carried 
out to determine morphology and surface characteristics of the different nanofiber 
nonwovens. Transmission electron microscopy was used to clarify the localization of the 
protein within the NN. PLLA NNs exhibited a highly hydrophobic surface which led to a 
slow wetting. It was shown that the protein release was dependent on the surface tension of 
the release medium. Electrospinning of emulsions consisting of an organic solution of PLLA 
and an aqueous solution of hydrophilic polymers yielded fibers composed of a polymer blend. 
The resulting NNs exhibited a less hydrophobic surface, which gave us the opportunity to 
tailor the release profile via this technology. Furthermore it was investigated how the addition 
of different amounts of hydrophilic polymer to the aqueous phase influenced the morphology 
of the resulting NNs. 
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Introduction 
Polymeric drug delivery systems are able to improve therapeutic efficacy, reduce toxicity, and 
enhance compliance of the patients by delivering drugs at a controlled rate over a period of 
time to the site of action. In particular biodegradable polyesters and their copolymers 
demonstrated their potential as effective carriers for drug delivery [1, 2]. Electrospinning is a 
remarkably simple and powerful technique for the generation of polymeric fibers in the sub-
micrometer scale, ranging from about 50 nm to several µm [3]. During the electrospinning 
process a polymer solution or melt is put through a capillary device to produce a droplet. This 
droplet of polymer solution is subject to a high electrical voltage (8 - 50 kV) which leads to 
electrostatic charging of the fluid and subsequently to formation of the so called Taylor cone 
[4]. At some point the electric force overcomes the surface tension of the droplet and a single 
fluid jet ejects at the apex of the Taylor cone. The jet accelerates in the electric field towards a 
counter electrode and undergoes a stretching and whipping process which leads to continuous 
elongation and solvent evaporation. Y.M. Shin et. al. investigated electrically forced jets in 
detail and came to the conclusion, that the rapidly whipping jet is a key step in the formation 
of submicron diameter fibers by electrospinning [5]. The polymeric fibers are collected on the 
counter electrode where they form a nonwoven fiber mat having a nano-structured surface. 
Electrospinning is applicable to many types of polymer solutions or melts and represents an 
attractive approach for polymeric biomaterials processing [6-9]. The resulting nanofiber 
nonwovens are useful in a range of applications in different areas of research. They are 
particularly interesting for the field of biomedical engineering as wound dressings, scaffolds 
for tissue engineering, and drug delivery systems [10-17].  
Encapsulation of low molecular weight drug substances like tetracycline hydrochloride [12], 
ibuprofen [18], rifampicin [8], and other molecules into electrospun NNs has already been 
demonstrated by a number of authors [19-24]. In most cases the drug was dissolved or 
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dispersed in the polymer solution and was encapsulated using a one phase electrospinning 
method. Only very few studies on the encapsulation and release of macromolecules like 
proteins  have been published [9, 25-27]. Encapsulation of higher molecular weight 
substances is more difficult, because the electrospinning of macromolecular dispersions is 
more challenging than electrospinning of homogenous polymer solutions. The concept of 
coaxial electrospinning led to core-shell structured fibers which proved their suitability as 
drug delivery devices for larger molecules, but special equipment is needed for these 
electrospinning techniques [28-30]. Another approach which has not been investigated very 
extensively until now is the electrospinning of emulsions [26, 27, 31, 32]. 
In this study we present the preparation of highly hydrophobic, protein loaded nanofiber 
nonwovens (NNs) based on poly(L-lactic acid) (PLLA) via electrospinning of emulsions and 
their characterization by SEM and gas adsorption measurements. Cytochrome C was chosen 
as a hydrophilic model protein due to the ease of detection and quantification methods 
available for this compound. The release of macromolecules was shown to be affected by the 
hydrophobicity of the NNs, and therefore, we were able to modify the release profiles by 
blending the PLLA with hydrophilic polymers such as poly(ethylene imine) (PEI) and poly(L-
lysine) (PLL). 
 
Materials and methods: 
Poly(L-lactide) (PLLA) Resomer L210 (inherent viscosity 3.6 dl/g) was purchased from 
Boehringer Ingelheim (Ingelheim, Germany). Poly(ethylene imine) (25 kDa, PEI) was a gift 
from BASF, Ludwigshafen, Germany. Poly(L-lysin) (PLL) was purchased from Sigma 
Chemical Co. (St. Louis, USA). Cytochrome C from horse heart was obtained from Fluka 
Chemie GmbH (Buchs, Germany). All other reagents used were of analytical grade. 
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Electrospinning 
Different emulsions were prepared in 5 ml syringes using an Ultra Turrax T25 running at 
20500 rpm for 1 minute. A setup published previously was used for electrospinning [33]. 
Electrospinning was carried out using a variable high-voltage power supply, which can 
produce voltages ranging from 0 to 55 kV. It consists of one positive power supply attached 
to a blunt steel needle and one negative power supply attached to the counter electrode.  The 
syringes containing the different emulsion were attached to the blunt needle and were put into 
a syringe pump pushing 50 µl of the emulsions per minute through the blunt needle. A round 
steel plate with a diameter of 9 cm served as the counter electrode. It was covered with 
aluminum foil for the collection of the different fibers.  
PLLA nanofiber nonwovens were prepared by emulsifying 0.5 ml of an aqueous solution of 
Cytochrome C (20 mg/ml) into 2 g of 1, 2, or 3 wt% PLLA in chloroform. The viscosity of an 
emulsion containing 2 wt% PLLA was 921 mPa  s. A voltage of +19 kV was applied at the 
needle tip, and –1 kV was applied at the counter electrode, which was 20 cm from the needle 
tip. In the case of PLLA / PEI and PLLA / PLL blends, the nanofiber nonwovens were 
prepared by dissolving either PEI or PLL in the aqueous phase before the emulsification into 
the chloroform containing PLLA. The content of PEI or PLL in the blends is presented as the 
wt% relative to the mass of PLLA. When electrospinning these blends, the applied voltage 
values were +20 kV at the needle tip and -2 kV at the counter electrode, with the distance 
maintained at 20 cm. 
 
SEM imaging 
Fragments of the nanofiber nonwovens were sputtered with gold in an argon atmosphere 
(0.3 mPa) using a sputter coater S-150 (Edwards Kniese & Co. GmbH, Marburg, Germany). 
Sputtering was carried out for each sample at 18 mA 2 times for 1 minute and after that 2 
 
64 
Electrospun biodegradable nanofiber nonwovens for controlled release of proteins 
times for 2 minutes. Images were taken with an SEM S-510 at 25 kV accelerating voltage 
(Hitachi Ltd. Corporation, Tokyo, Japan) using the Digital Imaging Scanning System 
(Version 5.4.12.1) purchased from point electronic GmbH, Halle (Saale), Germany. Images 
were analyzed with the Digital Image Processing System (Version 2.6.13.0) purchased from 
point electronic GmbH, Halle (Saale), Germany.  
 
TEM imaging 
Fragments of the nanofiber nonwovens were directly imaged by transmission electron 
microscopy (TEM) using a JEM 3010 operated at 300 kV without staining or cutting of the 
samples. Images were created by Digital Micrograph Software (Gatan Inc.). 
 
Contact angle 
Static contact angles of water on the nanofiber nonwoven surface were measured using the 
sessile drop method with a G10 Drop Shape Analysis System (Krüss GmbH, Hamburg, 
Germany). 5 µl deionized water were dropped onto a dry nanofiber nonwoven in air and the 
contact angle was calculated using Data Physics SCA20 Contact Angle Analyzer Software. 
 
Gas adsorption measurements 
Gas adsorption measurements were carried out using a BELSORP-mini (BEL Japan, Inc.) in 
high precision mode. In this mode the saturated vapor pressure and dead volume are corrected 
from the actual measurement. BELSORP-mini uses a volumetric gas adsorption method. 
Samples were pretreated using a heater for 24h at 37°C by vacuuming. Dead volume 
measurements were carried out at room temperature using helium gas. Adsorption and 
desorption measurements were performed with the sample cell and an empty reference cell 
immersed in liquid nitrogen to maintain a constant temperature. Dead volume changes due to 
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evaporation of liquid nitrogen. Therefore the dead volume of the reference cell was measured 
prior to every adsorption measurement. Nitrogen gas was used as adsorbent.  
 
Loading 
Loading of the nanofiber nonwovens was determined by degrading parts of the nanofiber 
nonwovens in 1 ml of 1 N NaOH. The amount of incorporated Cytochrome C was calculating 
by measuring the adsorption of the resulting solution at 412 nm using a UV/Vis 
spectrophotometer UV-160 (Shimadzu Corporation, Kyoto).  
 
Release profile 
Release studies were carried out in PBS buffer solution pH 7.4. Samples of the nanofiber 
nonwovens (2 cm x 2 cm) were put in 15 ml plastic tubes and 2 ml release medium was 
added. The tubes were constantly moved at a speed of 30 rpm at 37°C. At certain time points 
200 µl of the release medium were removed and replaced with fresh buffer solution. The 
amount of released cytochrome C was determined via BCA assay. 50 µl of the samples were 
mixed with 170 µl BCA reagent (BCA assay kit, Pierce, Rockford IL, USA) in 96 well plates. 
After 18h at ambient temperature the absorption at 560 nm was measured using a plate reader. 
All measurements were carried out in triplicate.  
 
Results and Discussion: 
1. Preparation  and characterization of nanofiber nonwovens 
At first the influence of the polymer concentration on the morphology of the resulting fibers 
was examined. Five different emulsions with a concentration ranging from 1 – 3 wt% poly(L-
lactic acid) in the organic phase were electrospun. With increasing polymer concentration the 
uniformity of the fibers and the mean fiber diameter increased (Fig.1 a-c).  
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Figure 14: SEM images of NNs with incorporated cytochrome C electrospun from emulsions having differently 
concentrated organic phases (a: 1% PLLA, b: 2% PLLA, c: 3% PLLA). NNs show different morphology 
depending on the polymer concentration. d: NN blended with 50% PEI shows comparable morphology to pure 
PLLA NNs. Addition of hydrophilic polymers leads to an significant increase in mean fiber diameter depending 
on the amount of added polymer (e). 
 
Especially at lower polymer concentrations structures that looked like burst beads were 
observed. These structures are most likely due to the formation of a polymeric skin on the 
liquid jet covering the droplets of the aqueous phase at first and then collapsing. Other groups 
have already reported similar fiber morphology even using one-phase electrospinning 
techniques [34-36]. As a consequence of the collapsing beads, not the whole amount of 
cytochrome C is encapsulated in the nanofibers. TEM images revealed crystallite structures 
having a size of 200 – 500 nm outside the fibers which are most likely composed of 
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cytochrome C (Figure 2). Nevertheless those protein crystals were still encapsulated within 
the nonwoven fiber mat. 
 
Figure 15: TEM images of NNs with incorporated cytochrome C electrospun from emulsions showing 
crystallite structures outside the fibers (a, b: examples of crystallite structures; c: magnification of figur 2b 
showing a periodic pattern, which is characteristic for crystallite structures). Samples were put on a supporting 
grid and directly imaged without any staining or embedding of the samples. 
 
 
Static contact angles of water on the NN surface were determined using a sessile drop 
method. No significant differences between NNs prepared from differently concentrated 
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polymer solutions were observed and the mean contact angle was 109.4  ± 5.9 ° (p < 0.05). 
The high contact angle of water on PLLA NNs shows their superhydrophobicity, which is the 
reason for the very slow wetting of these devices. The hydrophobicity of the PLLA NNs was 
reduced by addition of hydrophilic polymers like poly(ethylene imine) or poly(L-lysine) to 
the aqueous phase of the electrospinning emulsion. We chose charged hydrophilic polymers 
since they also increase the conductivity of our electrospinning emulsion. A higher 
conductivity facilitates electrospinning of these emulsions.  The morphology of the resulting 
polymer blend fibers was similar to pure PLLA fibers. Even with an addition of 50 % PEI 
there were no differences in the macroscopic fiber morphology visible on SEM images (Fig. 
1d). After analysis of the SEM images using the measuring tool of the “Digital Image 
Processing System” software it could be demonstrated that the mean fiber diameter increases 
significantly after addition of hydrophilic polymers with regard to the amount of added 
polymer (Fig 1e). Fibers electrospun from emulsions containing 2 wt% PLLA showed a mean 
fiber diameter of 346.6 ± 10.1 nm. The addition of 5% PEI to the aqueous phase of the 
emulsion led to a significant increase in mean fiber diameter to 383.4 ± 12.0 nm (p < 0.05). 
Further increases in PEI content in the blend fibers led to further increases in fiber diameter, 
with mean fiber diameters of 419.1 ± 10.8 nm at 10% PEI and 511.8 ± 13.1 nm at 50% PEI. It 
is expected that the addition of polyelectrolytes would increase charge density and decrease 
the fiber diameter [37]. In this case this effect is overcome by the increasing polymer 
concentration in the emulsion, which leads to an increase in mean fiber diameter. 
Native page gel electrophoresis was used to check whether the electrospinning process would 
have a negative effect on the protein. There were no visible changes in retention time between 
native cytochrome C and the cytochrome C released from the NNs. These results prove that 
neither degradation nor aggregation of the protein occurred during electrospinning. Other 
groups have also shown that electrospun proteins are stable and retain their bioactivity [9, 25]. 
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Usually NNs are characterized just by calculating their mean fiber diameter from SEM 
images. But since not just single nanofibers are used, but a nonwoven consisting of those 
nanofibers, we also wanted to examine the device as a whole. Gas adsorption measurements 
were carried out to characterize the surface properties of the NNs in detail. A volumetric 
method was used to determine the amount of adsorbed gas. After evacuation of the sample 
cell a specified amount of nitrogen gas was added to the sample cell. The pressure of 
adsorption gas in the sample cell decreases as adsorption occurs. The adsorption amount was 
measured by calculating the differences between pressures before and after gas adsorption or 
desorption respectively. To assure reproducibility of the experiment, five PLLA NNs that 
were prepared from 5 different emulsions having the same composition were characterized.  
 
Figure 16: a: Gas adsorption and desorption isotherm of a PLLA NN electrospun from an emulsion containing 
2% PLLA in the organic phase. b: BET plot of the PLLA NN which is used to calculate the specific surface area 
and mean pore diameter of the NN. c: Pore size distribution of different NNs is given in the BJH plot (PLLA: 
filled squares; PLLA/PEI 5%: open squares, PLLA/PEI 10%: stars, PLLA/PEI 50%: open circles). d: Blending 
of PLLA NNs leads to an decrease of the specific surface area. The mean pore diameter is not affected. 
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The resulting adsorption and desorption isotherms were highly reproducible for one NN and 
very similar in comparison to the other PLLA NNs, even though the amount of adsorbed gas 
was rather low. Figure 3a shows an adsorption and desorption isotherm of a PLLA NN 
electrospun from an emulsion containing 2 wt% PLLA in the organic phase. Adsorption 
isotherms are classified based on the strength of the interaction between the sample surface 
and adsorptive gas, and the existence or absence of pores. The desorption isotherms of the 
examined PLLA NNs show hysteresis compared to the adsorption isotherms. This effect can 
be explained by the presence of mesopores with a diameter of 2 – 50 nm on the surface of the 
fibers. Hysteresis occurs because capillary condensation of nitrogen gas takes place in 
mesopores and there is a difference in meniscus during adsorption and desorption. The 
monolayer volume of adsorbed gas (Vm) was determined according to the BET theory. The 
BET plot (Figure 3b) should give a linear line in a relative pressure range from 0.05 to 0.35 
and the slope of that line is used to determine Vm, from which we can calculate the specific 
surface area of the NNs. In this manner we determined a specific surface area of 13.17 m2/g ± 
2.15 for the PLLA NNs. NNs composed of nanofibers consisting of a polymer blend of PLLA 
and poly(ethylene imine) showed a decreased specific surface area with regard to the amount 
of added hydrophilic polymer (Figure 3d). An addition of 5% poly(ethylene imine) to the 
aqueous phase of the electrospinning emulsion does not decrease the specific surface area of 
the resulting NNs significantly (11.49 ± 0.70 m2/g), but the addition of 10% or 50% PEI led to 
a significantly decreased specific surface area (8.97 ± 0.82 m2/g for PLLA/PEI 10% and 7.43 
± 1.54 m2/g for PLLA/PEI 50%; p < 0.05). This effect is caused by the increased mean fiber 
diameter of the NNs composed of fibers consisting of a polymer blend. As demonstrated via 
SEM imaging, the mean fiber diameter increases significantly with increasing amount of 
hydrophilic polymer. This increase in mean fiber diameter will naturally result in a decrease 
in specific surface area. Considering the density of the adsorbent at 77 K it is possible to 
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specify the mean pore diameter of the sample. In this manner a mean pore diameter of 7.22 ± 
1.14 nm was calculated for the surface pores on PLLA fibers. Blending with PEI did not lead 
to significant differences in mean pore diameter (p < 0.05). The pore size distribution was 
determined from the desorption isotherm according to [38]. The so called BJH plot is 
expressed as percentage change of pore volume (Vp/rp) against mesopore diameter. BJH-
plots of all fibers showed a monomodal distribution of mesopores matching the calculated 
size from the BET plot (Figure 3c). All distributions showed a peak at a diameter of roughly 
4.5 nm. The addition of PEI did not have an influence on pore size distribution. 
 
2. Protein release characteristics  of nanofiber nonwovens 
Loading of the NNs has been determined after hydrolytic degradation of the polymer in basic 
solution. They showed high encapsulation efficiencies of 85% to 95%. Loading of each NN 
was determined prior to the release studies to calculate the release percentage of the actual 
protein content of every single NN. 
At first the influence of the polymer concentration in the organic phase on the release profile 
of PLLA NNs was investigated. For this purpose PLLA NNs electrospun from 1 wt%, 2 wt% 
or 3 wt% PLLA solution were immersed in PBS buffer solutions and the amount of released 
protein was determined via BCA assays. PLLA NNs electrospun from 2 wt% and 3 wt% 
solutions showed no burst release, implying the perfect inclusion of the protein within the 
NN. NNs prepared from emulsions containing only 1 wt% PLLA in the organic phase show a 
slightly increased release. Only very slow release of the incorporated protein can be observed 
in the following 30 days (Figure 4). Some studies about drug release from NNs have already 
been published. To clarify the release mechanism from NNs it is important to know where the 
drug is localized inside the NN. The encapsulation of lipophilic compounds usually leads to 
the drug being homogenously dispersed inside the fibers.  
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Figure 17: Release profiles of cytochrome C from PLLA NNs electrospun from emulsions having differently 
concentrated polymer solutions as organic phase. 
 
J. Zeng et. al. [8] encapsulated rifampicin in PLLA fibers using a one phase electrospinning 
technique. They observed a release of the drug only in the presence of the enzyme proteinase 
K which degrades the PLLA fibers. On the other hand hydrophilic compounds are usually 
located on the surface of the fibers. K. Kim et. al. [21] applied an one phase encapsulation 
technique for the encapsulation of the hydrophilic antibiotic cefoxitim sodium in poly(lactide-
co-glycolide) NNs. They observed a very high burst release due to limited physical 
interactions between drug and polymer matrix. We showed for our NNs, that Cytochrome C 
exists in crystallite form in between the fibers of the NNs (figure 2). Considering these 
findings one would expect at least some burst release for our hydrophilic model protein 
cytochrome C. The reason for the very slow release from the NNs described in this study is 
their very slow wetting as a consequence of the highly hydrophobic surface characteristics. 
The slightly increased release for NNs electrospun from 1 wt% solutions can be addressed to 
the decreased thickness of the NNs which leads to better wetting behavior. To clarify the 
effect of wettability on the protein release, another set of release studies was carried out using 
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release media having different surface tensions through the addition of an emulsifier. Prior to 
the release studies, the CMC of the emulsifier Tween 20 in PBS buffer solution was 
determined. After that 6 buffer solutions were prepared having emulsifier concentrations 
below the CMC, at the CMC, and above the CMC. Addition of an emulsifier to the release 
medium increased the protein release. Buffer solutions having an emulsifier concentration at 
the CMC or above the CMC led to complete release of the protein within a few hours. For 
concentrations below the CMC we determined a surface tension related release of the protein 
(Figure 5).  
 
Figure 18: Release profiles of PLLA NNs with incorporated cytochrome C determined in buffer solutions 
having different surface tensions (all concentrations of the emulsifier are below the CMC). 
 
 
Higher concentrations of Tween 20 led to a faster release of the incorporated protein. This 
proved that the wettability of the NNs is predominantly responsible for the release rate and 
that the major part of cytochrome C was encapsulated within the NN but not within the fibers 
itself. These results gave us the opportunity to tailor the release profile of the NNs by 
adjusting their hydrophobicity. Thus, we decided to produce NNs with less hydrophobic 
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surfaces via the addition of hydrophilic polymers to the aqueous phase of the electrospinning 
emulsion. NNs composed of these polymer blend fibers should show a faster protein release 
compared to pure PLLA NNs. Blending with hydrophilic polymers has already been applied 
by other groups to decrease the burst release of hydrophilic drug substances [18, 21]. In 
contrast to their approach our intention was to increase and control the drug release. For that 
reason aqueous poly(ethylene imine) 25 kDa (PEI) and poly(L-lysine) solutions were 
prepared. Cytochrome C was dissolved in these polymer solutions and the resulting solution 
was used as the aqueous phase of the electrospinning emulsions. The resulting NNs showed 
release profiles depending on the amount of added hydrophilic polymer (Figure 6). With 
increasing amount of hydrophilic polymers the hydrophobicity of the NNs was reduced and 
the protein release rate was increased. Blending of the NNs influenced primarily the initial 
release phase and resulted in the opportunity to tailor the release profile of the NNs. 
In summary, we present an electrospinning technique that allows the encapsulation of 
hydrophilic proteins in biodegradable NNs which do not show the common but unfavorable 
high burst release. Although it is known that electrospun NNs may have super-hydrophobic 
surfaces [39], this study showed the importance of that feature for drug release in detail and 
how it is possible to exploit this potential to adjust the release profile of these drug delivery 
devices. 
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Figure 19: Release profiles of PLLA NNs blended with different amounts of hydrophilic polymers (a: blended 
with PEI, b: blended with PLL). 
 
 
Conclusion: 
We showed the feasibility to prepare protein loaded nanofiber nonwovens via electrospinning 
of emulsions consisting of an organic polymer solution and an aqueous protein solution. SEM 
images demonstrated that the mean fiber diameter is in a nanometer scale and increases with 
increasing polymer concentration. The addition of hydrophilic polymers to the aqueous phase 
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of the electrospinning emulsion yielded NNs composed of nanofibers consisting of a polymer 
blend. Mean fiber diameters of these NNs increased with increasing amounts of hydrophilic 
polymer in the aqueous phase. Gas adsorption measurements were carried out to investigate 
surface properties in detail like specific surface area, mean pore size, and pore size 
distribution. We demonstrated that the increased fiber diameter of the NNs composed of 
polymer blend nanofibers led to a decrease of their specific surface area.  PLLA NNs 
exhibited a highly hydrophobic surface, which also proved to be the major criterion 
controlling the protein release. The release rate of PLLA NNs was rather slow, but NNs 
composed of nanofibers consisting of a polymer blend of PLLA and a hydrophilic polymer 
exhibited adjustable protein release rates depending on the amount of added hydrophilic 
polymer.  
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Summary 
A key requirement for tissue engineering is the design of a scaffold which exhibits suitable 
biological and physical properties. The incorporation of bioactive substances, which are 
essential for cell growth or differentiation, would also be very advantageous. In this study 
protein loaded nanofiber nonwovens (NNs) were prepared by electrospinning of emulsions to 
investigate their suitability as tissue engineering scaffold. The hydrophobicity of the resulting 
NNs was adjusted by the addition of hydrophilic polymers to the aqueous phase of the 
electrospinning emulsion. Five different NNs based on PLLA and blends thereof were 
investigated for their suitability as scaffolds for tissue engineering. The first part of this study 
demonstrated that NNs showed a mean fiber diameter of 350 – 500 nm, which is similar to the 
fibrous protein structures of the extracellular matrix (ECM). Cell adhesion, cell viability and 
cell morphology on different NNs were determined and compared to a glass surface. The 
results of this study demonstrated that there were no significant differences for cells grown on 
NNs compared to a glass surface. NNs composed of a blend of 95% PLLA and 5% PLL 
featured the most promising attributes for their use as tissue engineering scaffolds, since they 
showed significantly higher values for cell adhesion and the best cell spreading behaviour of 
all NNs. 
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Introduction 
Tissue engineering is an interdisciplinary field that applies the principles of engineering and 
life sciences towards the development of biological substitutes that restore, maintain, or 
improve tissue functions or a whole organ [1]. The creation of new tissues under in vitro 
conditions is based on three principles: the isolation and cultivation of cells, the use of tissue 
inducing substances and the placement of cells within suitable matrices or on polymeric 
scaffolds. The preparation of a scaffold which provides suitable biological and physical 
properties is a critical requirement for tissue engineering. Every tissue can be described as a 
microenvironment which is composed of parenchymal cells (functional cells) and 
mesenchymal cells (support cells) contained within an extracellular matrix (ECM). Therefore 
a suitable tissue engineering scaffold should mimic the nanofibrous features of the ECM. The 
scaffold material needs to be biocompatible, should promote cell adhesion and proliferation 
and in particular should support their three dimensional growth. Finally the scaffold should be 
biodegradable in order that the artificial matrix can be replaced by a new natural ECM after 
the differentiation of the seeded cells to viable tissue. 
The ECM in native tissues consists of fibrous proteins with a diameter of 50 – 500 nm. 
Electrospinning is a unique technology for the generation of polymeric fibers in the sub-
micrometer scale, ranging from about 50 nm to several µm [2]. This simple and versatile 
technique is applicable to many types of polymer solutions or melts and represents an 
attractive approach for the production of tissue engineering scaffolds with structures very 
similar to the ECM [3-8]. Furthermore, electrospinning of emulsions allows bioactive 
substances to be incorporated in these electrospun nanofiber nonwovens. These substances 
will be released from the fibers in a controlled manner for example to support cell growth or 
induce differentiation. Hence these scaffolds act not only as cell carriers but also as controlled 
release systems. 
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Standard electrospinning instrumentation usually consists of three major components: a high 
voltage power supply, a spinneret (a metal capillary, e.g. a needle with blunt tip) and a 
grounded collecting device (a metal plate or a rotating drum). During the electrospinning 
process a polymer solution or melt is pushed through the spinneret to produce a droplet. This 
droplet is subject to a high electrical voltage (8 - 50 kV) which leads to electrostatic charging 
of the fluid and subsequently to formation of the so called Taylor cone [9]. At some point the 
electric force overcomes the surface tension of the droplet and a single fluid jet ejects at the 
apex of the Taylor cone. The jet accelerates in the electric field towards a counter electrode 
and undergoes a stretching and whipping process which leads to continuous elongation and 
solvent evaporation [10]. The polymeric nanofibers are collected on the counter electrode 
where they form a nonwoven fiber mat. 
The objective of this study was to investigate the suitability of NNs based on PLLA for their 
application as tissue engineering scaffolds. The NNs were prepared via electrospinning of 
emulsions. The aqueous phase contained cytochrome C as a model substance for the 
incorporation of growth or differentiation factors which will be released from the NNs in a 
controlled manner. Cell adhesion, cell viability and cell morphology on these scaffolds 
composed of PLLA or blends of PLLA and hydrophilic polymers was determined and the 
impact of the addition of hydrophilic polymers was investigated.  
 
Materials and methods 
Materials 
Poly(L-lactide) (PLLA) Resomer L210 (inherent viscosity 3.6 dl/g) was purchased from 
Boehringer Ingelheim (Ingelheim, Germany). Poly(ethylene imine) (25 kDa, PEI) was a gift 
from BASF, Ludwigshafen, Germany. Poly(L-lysine) (PLL) was purchased from Sigma 
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Chemical Co. (St. Louis, USA). Cytochrome C from horse heart was obtained from Fluka 
Chemie GmbH (Buchs, Germany). All other reagents used were of analytical grade. 
 
Cell culture 
L-929 (mouse subcutaneous connective tissue; ATCC: CCL-1) cells were purchased from 
ATCC (Teddington, UK) and maintained in DMEM (PAA Laboratories, Cölbe, Germany) 
supplemented with 10% fetal calf serum (Cytogen, Sinn, Germany) in humidified atmosphere 
with 5% CO2 at 37 °C. 
 
Preparation of nanofiber nonwovens 
Different emulsions were prepared in 5 ml syringes using an Ultra Turrax T25 running at 
20500 rpm for 1 minute. A setup published previously was used for electrospinning [11]. 
Electrospinning was carried out using a variable high-voltage power supply, which can 
produce voltages ranging from 0 to 55 kV. It consists of one positive power supply attached 
to a blunt steel needle and one negative power supply attached to the counter electrode.  The 
syringes containing the different emulsion were attached to the blunt needle and were put into 
a syringe pump pushing 50 µl of the emulsions per minute through the blunt needle. A round 
steel plate with a diameter of 9 cm served as the counter electrode. It was covered with 
aluminium foil and round glass cover slips were used to collect the different fibers.  
PLLA nanofiber nonwovens were prepared by emulsifying 0.5 ml of an aqueous solution of 
Cytochrome C (20 mg/ml) into 2 g of 1, 2, or 3 wt% PLLA in chloroform. The viscosity of an 
emulsion containing 2 wt% PLLA was 921 mPa  s. A voltage of +19 kV was applied at the 
needle tip, and –1 kV was applied at the counter electrode, which was 20 cm from the needle 
tip. In the case of PLLA / PEI and PLLA / PLL blends, the nanofiber nonwovens were 
prepared by dissolving either PEI or PLL in the aqueous phase before the emulsification into 
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the chloroform containing PLLA. The content of PEI or PLL in the blends is presented as the 
wt% relative to the mass of PLLA. When electrospinning these blends, the applied voltage 
values were +20 kV at the needle tip and -2 kV at the counter electrode, with the distance 
maintained at 20 cm. 
 
SEM imaging 
Fragments of the nanofiber nonwovens were sputtered with gold in an argon atmosphere 
(0.3 mPa) using a sputter coater S-150 (Edwards Kniese & Co. GmbH, Marburg, Germany). 
Sputtering was carried out for each sample at 18 mA 2 times for 1 minute and after that 2 
times for 2 minutes. Images were taken with an SEM S-510 at 25 kV accelerating voltage 
(Hitachi Ltd. Corporation, Tokyo, Japan) using the Digital Imaging Scanning System 
(Version 5.4.12.1) purchased from point electronic GmbH, Halle (Saale), Germany. Images 
were analyzed with the Digital Image Processing System (Version 2.6.13.0) purchased from 
point electronic GmbH, Halle (Saale), Germany.  
 
Cell adherence on nanofiber nonwovens 
L929 cells were seeded onto cover slips which had been coated with nanofibers in 12-well 
plates at a density of 5x104 cells/well. Coated and uncoated glass cover slips were disinfected 
with 70 % isopropanol and dried under a laminar flow inside a clean bench. The dried glass 
cover slips were put in 12 well plates and L929 cells were seeded on the glass cover slips. 
After 48 hours the glass cover slips were removed from the medium and rinsed with PBS to 
make sure that only adherent cells remained on them. The cover slips were embedded using 
FluorSave Reagent (Calbiochem, San Diego, CA). Transmission light images were taken 
using a Zeiss Axiovert 100 M microscope (Zeiss, Oberkochen, Germany). Cell adhesion was 
determined by cell counting. 
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In a second experiment L929 cells were seeded onto cover slips which were coated with 
nanofibers in 12-well plates at a density of 105 cells/well. After 4 days the cells were lysed 
using cell culture lysis reagent (CCLR). The absolute protein content was determined by a 
BCA assay. 50 µl of the samples were mixed with 170 µl BCA reagent (BCA assay kit, 
Pierce, Rockford IL, USA) in 96 well plates. After 3 hours at 37°C and constant shaking the 
absorption at 560 nm was measured using a plate reader. All measurements were carried out 
in triplicate. 
 
Cell viability on nanofiber nonwovens 
Cell viability on nanofiber nonwovens was determined in triplicate by MTT assay according 
to  [12]. L929 cells were seeded onto cover slips which were coated previously with 
nanofibers in 12-well plates at a density of 105 cells/well. After 4 days cell culture medium 
was aspirated and replaced by DMEM without serum containing 0.5 mg/ml MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, Sigma, Deisenhofen, Germany). 
After 4 h incubation at 37 °C in the dark, the medium was aspirated and formazan crystals 
were dissolved in 200 μl dimethylsulfoxide per well. Measurement was performed using an 
ELISA reader (Titertek Plus MS 212, ICN, Eschwege, Germany) at a wavelength of 570 nm 
and 690 nm. 
 
Cell morphology on nanofiber nonwovens 
L929 cells were seeded onto cover slips which were coated previously with nanofibers in 12-
well plates at a density of 5x104 cells/well. After 48 hours the cells were washed with PBS, 
fixed using 4% paraformaldehyde in PBS, cell nuclei were stained with 4,6-diamidino-2-
phenylindole (DAPI) and the cells were washed again. Subsequently, cell membranes were 
labeled with fluorescein isothiocyanate-labelled wheat germ agglutinin (FITC-WGA). Finally 
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cells were embedded using FluorSave Reagent (Calbiochem, San Diego, CA). A Zeiss 
Axiovert 100 M microscope coupled to a Zeiss LSM 510 scanning device (Zeiss, 
Oberkochen, Germany) was used for confocal microscopy. The microscope was equipped 
with a Zeiss Neofluor 63*/1.2 objective. Excitation wavelengths were 364 nm (band pass 
filter 385 – 470 nm) for DAPI and 488 nm (long pass filter 505 nm) for FITC. Transmission 
images were obtained in the same scan.  
 
Statistical analysis 
All quantitative results were carried out at least in triplicate. Data is expressed as mean ± SD. 
Statistical analysis was carried out using an unpaired student’s t-test. A value of p < 0.05 was 
considered to be statistically significant. 
 
Results and discussion 
In this study the technique of electrospinning of emulsions was applied to generate protein 
loaded NNs. All emulsions were composed of an organic PLLA solution in methylene 
chloride and an aqueous cytochrome C solution. The aqueous phase of the emulsions 
contained cytochrome C as a model substance for the incorporation of growth or 
differentiation factors which play an important role in tissue engineering. The successful 
incorporation of the protein and its controlled release from the NNs was already demonstrated 
in a previous publication [13]. The objective of this study was to clarify wether nanofiber 
nonwovens prepared via electrospinning of emulsions met the requirements for a tissue 
engineering scaffold. Suitable scaffolds for tissue engineering have to be biocompatible and 
biodegradable. They should physically resemble the natural structures of the extracellular 
matrix (ECM), promote cell adhesion, cell proliferation and support three dimensional cell 
growth. 
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The NNs of this study were composed of Poly(L-lactide) (PLLA), which is a biodegradable 
aliphatic polyester that is very popular for use in medical applications. PLLA L210 was 
chosen for the preparation of nanofiber nonwovens (NNs) since its rather high molecular 
weight facilitates electrospinning and the resulting fibers showed almost no swelling in 
aqueous environments. Furthermore, L-lactic acid, the product of PLLA hydrolysis, is 
biocompatible since it occurs naturally in the metabolic pathway of human beings. For these 
reasons, PLLA nanofibers have attracted the interest of numerous researchers in the field of 
tissue engineering and drug delivery [13-16]. 
Native page gel electrophoresis was used to check whether the electrospinning process would 
have a negative effect on the protein. There were no visible changes in retention time between 
native cytochrome C and the cytochrome C released from the NNs (data not shown). These 
results proved that neither degradation nor aggregation of the protein occurred during 
electrospinning. Other groups have also shown that electrospun proteins were stable and 
retained their bioactivity [17, 18]. 
Cell adhesion to artificial materials is affected by their surface properties such as wettability, 
roughness, surface charge and chemical functionalities [19]. Protein adsorption to polymeric 
surfaces is also an important factor since it usually takes place prior to cell adherence [20-22]. 
With respect to surface wettability of polymeric materials, cells effectively adhere onto 
surfaces presenting moderate wettability with water contact angles of 40 – 70° [23-27]. Static 
contact angles of water on PLLA NNs of this study were 109.4° ± 5.9, which showed their 
super hydrophobic surface characteristics. This phenomenon is also know for other 
nanofibrous structures [28]. To improve cell adherence the hydrophobicity of the PLLA NNs 
was reduced by addition of hydrophilic polymers like poly(ethylene imine) or poly(L-lysine) 
to the aqueous phase of the electrospinning emulsion. It was not possible to determine 
comparable contact angles of water on the NNs composed of these polymer blends, since the 
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NNs absorbed the water droplet very fast and easily. Charged hydrophilic polymers were 
chosen for blending, since they also increased the conductivity of the electrospinning 
emulsion. A higher conductivity facilitates electrospinning of these emulsions. The 
morphology of the resulting polymer blend fibers was similar to pure PLLA fibers. After 
analysis of the SEM images using the measuring tool of the “Digital Image Processing 
System” software it could be demonstrated that the mean fiber diameter increased 
significantly after addition of hydrophilic polymers with regard to the amount of added 
polymer.  
 
Figure 20: SEM image of PLLA nanofiber nonwoven (a) and analysis of mean fiber diameters of differently 
composed nanofibers (b). 
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Fibers electrospun from emulsions containing 2 wt% PLLA showed a mean fiber diameter of 
346.6 ± 10.1 nm (Figure 1). The addition of 5% PEI to the aqueous phase of the emulsion led 
to a significant increase in mean fiber diameter to 383.4 ± 12.0 nm (p < 0.05). Further 
increases in PEI content in the blend fibers led to further increases in fiber diameter, with 
mean fiber diameters of 419.1 ± 10.8 nm at 10% PEI and 511.8 ± 13.1 nm at 50% PEI. It was 
expected that the addition of polyelectrolytes would increase charge density and decrease the 
fiber diameter [29]. In this case this effect was overcome by the increasing polymer 
concentration in the emulsion, which led to an increase in mean fiber diameter. The structural 
ECM proteins in native tissues have diameters of 50 – 500 nm. Since the diameter of our 
fibers ranged between 350 and 500 nm, the NNs produced by this electrospinning method 
perfectly matched the size of these structural proteins and should be very good in mimicking 
the native ECM. 
The above mentioned results demonstrated that the NNs met the morphological requirements 
for a tissue engineering scaffold. In summary, our NNs were able to physically resemble the 
nanofibrous features of the ECM, they were biocompatible and biodegradable and we were 
able to incorporate bioactive substances. In a next step, interactions of a model cell line 
(L929) with these NNs were investigated to examine their biological suitability as tissue 
engineering scaffolds. 
The first biological prerequisite for a suitable tissue engineering scaffold is to assure 
sufficient cell adhesion of the seeded cells. Only adhering cells are able to proliferate and 
differentiate to a tissue. For that reason, cell adhesion on different NNs was compared to the 
cell adhesion on a glass surface. Round glass cover slips were covered with nanofibers via 
electrospinning of emulsions. L929 mouse fibroblasts were seeded on theses cover slips and 
after 2 days cell adhesion was determined by cell counting on transmitted light images 
(Figure 2).  
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Figure 21: L929 cells grown on a glass surface (a) and cells grown on a PLLA nanofiber nonwoven. 
 
Using these procedures we compared cell adherence on a glass surface with nanofibers 
consisting of either pure PLLA or blends of PLLA and hydrophilic polymers. As mentioned 
previously, the addition of PEI or PLL should primarily decrease the hydrophobicity of the 
NN surface. For that reason, the blends were composed of only 5 or 10% of the hydrophilic 
polymers. Furthermore the addition of positive charges to the NNs should lead to higher cell 
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adherence through electrostatic attraction. It is commonly know, that cell membranes are 
negatively charged and a positively charged surface should therefore be more attractive for 
cell adherence than a neutral or negatively charged surface. 
Our results showed that cell adhesion on all fibers was as good as on a glass surface. 
Moreover, the number of cells adhering on nanofibers consisting of 95% PLLA and 5% PLL 
was significantly higher than on a glass surface or pure PLLA nanofibers (Figure 3a). 
Allowing the cells to grow for more than two days, led to a cell density which made it 
impossible to count their number on transmitted light images. A common experiment to 
determine cell density would be the detachment of the seeded cells from the surface and 
counting of the cell number using a hemocytometer. Usually the treatment of adhering cells 
with trypsin leads to the detachment of the cells. But cells grown on NNs were so strongly 
attached to the NNs that even high concentrations of trypsin and long incubation times did not 
lead to a detachment of the cells. This might by due to tight cell-matrix connections, which 
also occur in natural tissues between cells and the ECM. These adhesion sites are termed focal 
contacts or focal adhesions and are integrin-based structures that mediate strong cell-substrate 
adhesion [30]. These filament-like structures of 10-15 nm length extend from the cell body 
and attach to the nanofibers [14, 31].  
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Figure 22: Comparison of cell adherence on different surfaces determined by cell counting on transmitted light 
images (a) and calculated via protein quantification (b). 
 
Another experiment was carried out, which should on the one hand verify the results of the 
cell counting experiment via a second detection method and on the other hand should monitor 
cell adherence after a longer period of time. Round glass cover slips were coated with the 
same composition of nanofibers like in the first experiment. After 4 days the glass cover slips 
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were removed from the medium and rinsed with PBS to make sure that only adherent cells 
remained on them. The glass cover slips were put in 12 well plates and the adherent cells were 
lysed using cell culture lysis reagent (CCLR). After that, the protein content per well was 
determined via a BCA assay. It is obvious that a higher cell density led to higher protein 
content, which provided the possibility of an indirect determination of the cell adherence after 
4 days. The outcome of this experiment confirmed the findings of the cell counting 
experiment. There were no significant differences in cell adherence between a glass surface 
and NNs except for nanofibers consisting of 95% PLLA and 5% PLL, which showed a 
significantly higher cell adherence compared to glass or pure PLLA nanofibers (Figure 3b). 
Since neither the transmitted light images nor the protein content gave evidence whether the 
cells are still alive, we determined cell viability on coated and uncoated cover slips via a MTT 
assay. Yellow MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a 
tetrazole) is reduced to purple formazan in the mitochondria of living cells. This reduction 
takes place only when mitochondrial reductase enzymes are active, and therefore conversion 
can be directly related to the number of viable cells. Cell viability on the glass surface was 
normalized to 1.0 and cell viabilities on the different NNs were related to the cell viability on 
the glass surface. The results in figure 4 demonstrate that there were no significant differences 
in cell viability between a glass surface and the NNs.  
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Figure 23: Cell viability on different surfaces determined via MTT assay. 
 
 
After cells started to adhere on a surface, they will usually begin to spread on this surface. 
This is an essential step towards cell differentiation and proliferation. Confocal laser scanning 
microscopy was used to take a closer look on the morphology of the adhering cells on 
different surfaces. Cell nuclei were labeled with 4,6-diamidino-2-phenylindole (DAPI), which 
made them appear blue on the images. Cell membranes were stained with fluorescein 
isothiocyanate-labelled wheat germ agglutinin (FITC-WGA), which made them appear green. 
In this experiment cell morphologies of adhering cells on 4 different surfaces were compared. 
These surfaces were glass, a PLLA film on glass, PLLA nanofibers, and PLLA-PLL 5% 
nanofibers. Figure 5a shows the morphology of L929 cells which were seeded on a glass 
surface after 48 hours. All cells spread on the glass surface in two or more directions. Figure 
5b shows cell morphology on a PLLA film. Many cells on the PLLA film showed a spherical 
morphology and only some a spindle like structure. The PLLA film was rather hydrophobic 
and this attribute limited spreading of the cells. The small spherical structures on this picture 
were air inclusions which were generated during manufacturing of the film via spincoating. 
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As mentioned before, pure PLLA nanofiber nonwovens exhibited a super hydrophobic 
surface. This is the reason why the L929 cells on PLLA nanofibers were almost completely 
spherical and showed only small signs of spreading (Figure 5c). The addition of PLL 
decreased the hydrophobic features of the fibers and led to a spreading behavior which was as 
good as on a glass surface. In contrast to PLLA film or fibers, all cells spread on the surface 
of PLLA-PLL 5% fibers in two or more directions. 
 
Figure 24: CLSM images showing morphology of cells grown on different surfaces (a: glass, b: PLLA film, 
c: PLLA nanofiber nonwoven, c: PLLA – PLL 5% nanofiber nonwoven). 
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One major prerequisite for a tissue engineering scaffold is the support of three dimensional 
growth for the seeded cells. Confocal laser scanning microscopy is able to produce images of 
various z axis planes of the sample. By putting several images of different planes from the 
same sample on top of each other, a 3 dimensional view of the sample was assembled. Using 
this procedure, cross-sections of fluorescence labelled cells on nanofiber nonwovens were 
obtained.  
 
Figure 25: Z-stacks of CLSM images showing cross-sections of L929 cell nuclei (blue) grown on different 
nanofiber nonwovens (A: PLLA NNs, C: PLLA – PLL 5% NNs, C: PLLA – PLL 10% NNs) 
 
Figure 6 shows the cross-sections of PLLA NNs (A), PLLA-PLL 5% NNs (B), and PLLA-
PLL 10% NNs (C). The glass cover slip, which held the NNs is located at the bottom of each 
image. The blue spherical structures represent the cell nuclei of L929 cells. FITC-WGA was 
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originally used for staining of cell membranes, but it also adhered to the fibers to a small 
extend. In this way it was possible to estimate the thickness of the different NNs. The images 
proved that the addition of hydrophilic polymers led to water uptake and swelling of the NNs. 
This swelling behaviour depended on the amount of added hydrophilic polymer. A higher 
fraction of PLL led to a higher water uptake and swelling. Nevertheless the cells were still 
adhering to the nanofibers and were growing throughout the whole fibrous network. This gave 
the cells the opportunity to proliferate in all 3 dimensions and demonstrated the ability of the 
NNs to support three dimensional growth. 
 
Conclusion 
In this study, we succeeded in manufacturing protein loaded and biodegradable nanofiber 
nonwovens for the application in tissue engineering. It was demonstrated that the nanofibrous 
structure of this scaffold was similar to the natural ECM regarding fiber diameter. Favorable 
interactions between L929 cells and the scaffold were demonstrated by cell adhesion, cell 
viability and cell morphology studies. Furthermore, the addition of hydrophilic polymers gave 
us the opportunity to tailor the properties of these nanofiber nonwovens. Nanofiber 
nonwovens composed of 95% PLLA and 5% PLL featured the most promising 
characteristics. These results strongly suggest a huge potential of these nanofiber nonwovens 
for their application in tissue engineering. 
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Microencapsulation techniques based on phase separation and coacervation 
Microencapsulation has been widely used in many industrial applications, including graphics, 
food and agriculture. Application of microparticulate delivery systems for pharmaceutical and 
medical problems has also been extensively studied. Microencapsulation technology allows 
protection of the drug from the environment, stabilization of sensitive drug substances, 
elimination of incompatibilities or masking of unpleasant taste. Microparticles are particularly 
interesting for the development of controlled or prolonged release dosage forms. They play an 
important role as drug delivery systems aiming at improved bioavailability of conventional 
drugs and minimizing side effects. 
Pharmaceutical applications of microspheres comprise different routes of administration 
among them oral, pulmonary, and parenteral delivery can be distinguished. Microparticles are 
consequently administered either as dry powders, e.g. by inhalation or in form of an aqueous 
suspension, e.g. by injection. Our considerations will be mainly limited to the parenteral route 
of administration.     
The term “microencapsulation” is used to designate a family of technologies used to entrap 
solids, liquids or gases inside a polymeric matrix or shell. In contrast to film coating 
techniques, particle formation occurs in one single step. Usually the drug substance is 
encapsulated in a biocompatible or biodegradable polymer forming particles with a diameter 
in the size range of 1 - 1000 µm. As parenteral delivery system the diameter of the 
microparticles should be <250 µm, ideally <125 µm, to allow injections with acceptable 
needle diameters. 
Two general micro-morphologies of microparticles can be distinguished: microcapsules and 
microspheres. The term “microcapsule” should be used to describe particles in which a drug 
containing core is completely surrounded by a polymer shell. The core can be solid, liquid or 
gas; the shell is a continuous, porous or non-porous, polymeric layer. On the other hand 
“microspheres” are defined as microparticles in which the drug substance is either 
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homogeneously dissolved or dispersed in a polymeric matrix. These monolithic delivery 
systems can also be described as solid solutions or solid dispersions of the drug in a micro-
scale polymeric matrix. Microspheres show different release properties compared to true 
microcapsules and an additional feature is that catastrophic drug burst due to rupture of the 
shell cannot occur. 
With the recent progress in biotechnology and genetic engineering a large number of protein 
drugs have found therapeutic application. In most cases these bioactive agents are ineffective 
after peroral administration since they are rapidly degraded and deactivated by proteolytic 
enzymes in the gastro-intestinal tract. Furthermore their molecular weights are usually too 
high for oral absorption. Due to their short biological half-lives, frequent injections or 
infusion therapy are needed to achieve therapeutic plasma levels for prolonged periods of 
time. Biodegradable parenteral delivery systems, such as implants or microparticles have 
proven their suitability as parenteral depot systems for the administration of proteins and 
polypeptides. DNA and oligonucleotides are another challenging class of therapeutic agents 
which have also been successfully encapsulated. 
In this chapter we describe microencapsulation techniques which are relevant for the 
preparation of microparticles for parenteral depot delivery systems on an industrial scale. 
After a short summary of the most common biodegradable polymers which are used for this 
purpose, different techniques will be explained in more detail and examples will be given of 
pharmaceutical dosage forms prepared by these methods. 
 
Biodegradable Polymers 
Many different polymers are used in pharmaceutical sciences and technology as excipients, 
drug delivery systems, bandage-, suture- or packing materials. For parenteral depot systems, 
at first synthetic non-degradable polymers were used as drug carriers, diffusion barriers or 
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protective coatings. But since the 1970s new polymer materials emerged, degrading in a 
biological environment. For drug delivery a biodegradable polymer and its degradation 
products have to be biocompatible and toxicologically harmless. Biodegradable polymers are 
advantageous for all those cases, where the removal of the device is inconvenient or even 
impossible. 
Biodegradable polymers were first used as biomaterials for the manufacturing of absorbable 
sutures [1-3] and orthopaedic fixture materials [4]. After that they attracted a great deal of 
attention for drug delivery [5] and tissue engineering [6]. Since then the search for new 
biodegradable polymers progressed to design polymers for specific applications [7].  
Biodegradable polymers can be classified based upon the mechanism of erosion. It is essential 
to recognize that “degradation” refers to the chemical process of bond cleavage whereas 
“erosion” is a physical phenomenon dependent on dissolution and diffusion processes. Two 
mechanisms of polymer erosion can be distinguished: surface and bulk erosion. Surface 
eroding devices degrade by enzymatic or hydrolytic cleavage starting from the surface. In an 
ideal case the interior of the device contains unchanged polymer in the dry state. Bulk eroding 
devices degrade from the “inside” and hence water uptake precedes degradation of the 
polymer mostly by hydrolytic cleavage reactions. As a consequence the molecular weight of 
the polymer decreases until the cleavage products become water soluble. The interior of the 
devices retains drug and cleavage products in an aqueous milieu. In many cases both 
mechanisms occur concurrently, but the relative extend of surface or bulk erosion varies 
depending on the structure and composition of the biodegradable polymer. Surface erosion is 
considered most desirable, because the kinetics of erosion, and hence the rate of drug release, 
is more predictable and the drug substance is not exposed to an acidic environment generated 
by hydrolytic cleavage products from e.g. polyesters. The erosion mechanism depends in 
particular on the rate of water permeation in comparison to the rate of bond cleavage and 
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consequently diffusion of degradation products. In case water permeates faster into the 
polymer matrix than erosion takes place, bulk erosion can be expected. On the other hand 
surface erosion occurs if the rate of erosion exceeds the rate of water permeation into the bulk 
of the polymer. 
Controlled release dosage forms improve the effectiveness of drug therapy by increasing 
therapeutic activity compared to the intensity of side effects or reducing the number of drug 
administrations required during treatment. A variety of biodegradable polymers have been 
synthesized for the controlled release of different drugs. The selection and design of a suitable 
biodegradable polymer is the first challenging step for the development of a parenteral drug 
delivery system. Several classes of synthetic polymers have been proposed, including 
poly(ester)s, poly(anhydride)s, poly(carbonate)s, poly(amino acid)s, poly(amide)s, 
poly(urethane)s, poly(ortho-ester)s, poly(iminocarbonate)s and poly(phosphazene)s. In the 
following part the most common classes of biodegradable polymers are briefly introduced. A 
detailed discussion is beyond the scope of this chapter and the reader is referred to the 
literature. 
 
Poly(ester)s 
The most widely investigated class of polymers with regard to toxicological and clinical data 
comprise aliphatic poly(ester)s consisting of lactic and glycolic acid. Their corresponding 
polymers, poly(lactic acid), poly(glycolic acid) and copolymer poly(lactic-co-glycolic acid) 
have found wide-spread commercial application as drug delivery devices. Some of these drug 
delivery devices will be presented later in this chapter. 
Since high molecular weight polymers of glycolic and lactic acid cannot be obtained by 
condensation of the related hydroxycarboxylic acids, the polymers are usually produced by 
ring-opening polymerization of their cyclic dimers (Figure 1).  
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Figure 1: Ring-opening polymerization of poly(lactide) (R=H) or poly(glycolide) (R=CH3) 
 
Lactic acid contains an asymmetric -carbon which is typically described as D or L form and 
thus three different polymers are conceivable: poly(L-lactic acid), poly(D-lactic acid) and 
poly(DL-lactic acid). To date, poly(L-lactide) and poly(DL-lactide) have received the most 
attention among these poly(lactide)s. The stereochemistry of the polymers affects their 
mechanical, thermal and biological properties. Poly(lactide-co-glycolide) represents the “gold 
standard” of biodegradable polymers. The properties of these copolymers can be modified by 
changing the ratio of poly(lactide) and poly(glycolide). 
The mechanism of degradation in poly(ester)s is classified as bulk degradation with random 
hydrolytic scission of the ester bond linkages in the polymer backbone. In larger devices the 
acidic degradation products can accumulate in the polymer matrix due to reduced diffusion. 
This leads to an autocatalytic effect on the degradation of the device.  
Another polymer with excellent biocompatibility is poly(ethylene glycol). One reason for its 
high biocompatibility is the hydrophilic nature of poly(ethylene glycol). This attribute leads to 
formation of hydrogen bonds between water and the polymer chains which also inhibit 
protein adsorption. Thus poly(ethylene glycol) chains at the surface of a parenteral device 
lead to increased blood circulation times by prolonging biological events such as endocytosis 
or phagocytosis. Furthermore, block copolymers of poly(ethylene glycol) and poly(lactide) or 
poly(lactide-co-glycolide) have been synthesized for the encapsulation of proteins [8]. 
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Macromolecules which are incorporated into devices made from these copolymers are less 
likely to adsorb to the delivery system through hydrophobic interactions. 
 
Poly(anhydride)s 
Poly(anhydride)s are more hydrophobic than poly(ester)s and yet contain water sensitive 
bonds. This reduces the water permeation into the polymer bulk and hence poly(anhydride)s 
are believed to undergo predominately surface erosion by cleavage of the anhydride bonds at 
the surface of the device. The most widely studied poly(anhydride)s are based on sebacic 
acid, p-(carboxyphenoxy)propane and p-(carboxyphenoxy)hexane (Figure 2). Sipos et al. 
were able to improve the interstitial administration of an antitumor agent using a loaded 
polymer disc composed of poly(carboxyphenoxypropane-sebacic acid) [9]. 
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Figure 2: Structures of Poly(anhydride)s based on monomers of sebacic acid (A), p-(carboxyphenoxy)propane 
(B for x = 3) and p-(carboxyphenoxy)hexane (B for x = 6). 
 
For the design of parenteral drug delivery systems the selection of the biodegradable polymer 
is a very important consideration because solubility properties define the scope of 
microencapsulation technologies that can be used on one hand and the drug release and 
degradation properties on the other hand. It should be noted that the biodegradable polymer is 
an integral part of the device and should not be regarded as an inert excipient. Different 
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microencapsulation techniques were used to manufacture parenteral delivery systems on a 
commercial scale. These techniques can be classified as WOW-double emulsion method, 
phase separation techniques and spray drying. Phase separation and coacervation will be 
discussed in detail in the following section. 
 
Phase separation and coacervation 
Carbonless copy paper was the first commercially successful product containing 
microcapsules. The original microencapsulation technique to produce these pressure-sensitive 
dye microcapsules was described by Green and Schleicher in the 1950s and is based on 
macromolecular coacervation [10, 11]. The Dutch scientists Bungenberg de Jong and Kruyt 
introduced the term “coacervation” in 1929 [12]. It is derived from the Latin word 
“coacervus” which means heap or pile. Coacervation describes macromolecular aggregation 
processes brought about by partial desolvation of fully solvated macromolecules. A 
distinction is drawn between “simple coacervation” and “complex coacervation”. In simple 
coacervation processes phase separation is induced by addition of alcohol or salt, temperature 
change or pH change. In complex coacervation an oppositely charged polymer is added to the 
polymer solution leading to the formation of a coacervate phase via anion-cation interactions. 
These phase separation processes can be used to encapsulate solid or liquid drug particles 
which are dispersed in the polymer solution. The encapsulation process involves three main 
stages (Figure 3): 
 
1. Phase separation of the primary wall polymer solution is induced by one of the above 
mentioned methods. This leads to a three phase system consisting of a polymer-rich 
liquid phase (coacervate phase), a polymer-lean liquid phase and a solid or liquid 
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phase made up of the drug particles. This suspension or emulsion is usually 
maintained by continuous agitation. 
2. The polymer-rich phase deposits as microdroplets on the interface of the dispersed 
drug particles. After that the microdroplets start to spread which leads to fusion into a 
membrane. 
3. The originated polymer membrane is hardened through thermal, desolvation or 
chemical methods.  
 
 
 
Figure 3: Schematics representation of microencapsulation through coacervation: (A) dispersed liquid or solid 
drug particles; (B) induction of phase separation; (C) deposition of microdroplets at the surface; (D) fusion into 
a membrane. 
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A simple coacervation process can easily be demonstrated in an aqueous gelatin solution in 
which the solid or liquid drug is dispersed. Dropwise addition of a competing substance of 
greater hydrophilicity or concentration, such as an alcohol, will lead to phase separation 
resulting in the two liquid phases: one phase in which the concentration of gelatin is high and 
a second phase with a low gelatin concentration. This phase separation process takes place 
because the water-alcohol interactions in the gelatin solution are more favorable than the 
water-gelatin interactions. As a result the macromolecules are partially desolvated. This, in 
turn, leads to increased interactions between gelatin molecules themselves, and hence to the 
formation of macromolecular aggregates or coacervates. The individual polymer coacervates 
form the polymer-rich coacervate phase which deposits on the interface of the dispersed solid 
or liquid drug particles. 
The coacervation of gelatin and gum arabic (acacia) is an example of a complex coacervation 
process. The first step is to prepare a solution of gelatin and a solution of gum arabic in 45-
55°C water. The drug is dispersed or emulsified in the gelatin solution at above 45°C. The 
resulting suspension or emulsion is then diluted by addition of water and gum arabic solution. 
After that the pH is adjusted to below the isoelectric point of gelatin (3.8 - 4.4) so that its 
charge becomes positive while that of the acacia is negative. At this point the system is 
allowed to cool down to room temperature while being stirred. During this cooling process, 
the liquid coacervate slowly deposits around the drug particles forming microparticles. As a 
last step the mixture is cooled below 10 °C and glutaraldehyde is added to crosslink the 
polymers and to harden the polymer shell. 
Gelatin and acacia are both water soluble and hence the above mentioned classical methods 
are referred to as aqueous coacervation techniques. Since the use of water-insoluble polymers 
(e.g. many biodegradable polymers) in pharmaceutical technologies increased, new non-
aqueous coacervation techniques have been developed. These non-aqueous coacervation 
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techniques are also referred to as organic phase separation. Desolvation is induced by 
temperature change, addition of a low molecular weight non-solvent for the polymer or in 
most cases by polymer-polymer incompatibility.  
If two chemically different polymers are dissolved in a common solvent they usually separate 
into two phases as a consequence of incompatibilities. One phase is rich in one polymer, 
whereas the second phase is rich in the second polymer. For microencapsulation the polymer 
that serves as the capsule shell is dissolved in an organic solvent. Then the material to be 
encapsulated is introduced and a suspension or an emulsion is formed. To this mixture the 
second polymer solution is added to induce phase separation by polymer-polymer 
incompatibility. The desired coating polymer has to deposit preferentially on the surface of 
the drug for successful microencapsulation. After that the mixture is usually cooled down and 
the embryonic capsule walls are either chemically cross-linked or hardened by removal of the 
solvent. 
 
Application in pharmacy 
The preparation of microcapsules by coacervation for pharmaceutical purposes started in the 
1960s. Phares and Sperandio were one of the first to investigate the phenomenon of 
coacervation as a new way of coating pharmaceuticals [13, 14]. They used a simple 
coacervation method to encapsulate five solids and two liquids by addition of sodium sulfate 
to an aqueous gelatin solution. Among those solids were drugs like acetylsalicylic acid and 
procaine penicillin G. Nixon, Khalil and Carless investigated the role of pH and the effect of 
electrolytes on coacervation in the systems gelatin-water-ethanol and gelatin-water-sodium 
sulfate. They then presented an improved aqueous simple coacervation method for 
microcapsules containing sulphamerazine [15-17]. Luzzi and Gerraughty used the classical 
aqueous complex coacervation technique with gelatin and acacia to produce microcapsules 
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containing pentobarbituric acid and investigated the effect of additives and formulation 
techniques on controlled release of the drug from the microcapsules [18, 19]. 
Other polymeric systems have also been described for the preparation of microcapsule 
products via aqueous coacervation techniques. Merkle and Speiser prepared phenacetine-
loaded microcapsules by simple coacervation of a cellulose acetate phthalate solution through 
addition of sodium sulfate [20]. Mortada et. al. used gelatin and Gantrez-AN, a hydrolyzed 
copolymer of maleic anhydride and methyl vinyl ether, for a complex coacervation technique 
to produce nitrofurantoin-loaded micrcapsules [21, 22].  
Today biodegradable polymers like poly(lactide) (PLA) and poly(lactide-co-glycolide) are the 
most attractive polymers for microencapsulation of bioactive drugs like peptides, proteins and 
hormones. Since these polymers are water-insoluble, many organic phase separation 
techniques have been developed. The first method to prepare polyester microspheres was 
described probably for the first time in 1978 [23]. In the early 1980s the luteinizing hormone-
releasing hormone analogue nafarelin was encapsulated into poly(D,L-lactic-co-glycolic)acid 
by a phase separation process [24, 25]. These microspheres represented one of the first 
industrial developments of a controlled peptide release system for parental application. Since 
then, a great variety of peptide and protein compounds have been investigated. 
Two commercially available pharmaceuticals containing microparticles which have been 
prepared by a phase separation technique are Decapeptyl® Depot (Ferring Pharmaceuticals) 
and Sandostatin®-LAR® Depot (Novartis Pharma). Decapeptyl® Depot is composed of 
triptorelin-loaded PLGA-microspheres for the treatment of prostate cancer of men [26] or the 
treatment of infertility of women. Sandostatin®-LAR® Depot consists of octreotide acetate-
loaded PLGA-microspheres for the treatment of acromegaly, a disease resulting from a 
growth hormone secreting pituitary adenoma [27, 28].  
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Long-term treatment of acromegaly with octreotide would require three subcutaneous 
injections a day. Comets et al. described the absorption profiles of octreotide pamoate-loaded 
microspheres (Figure 5) in comparison to an i.v. application of octreotide solution (Figure 4) 
[29].  
 
Figure 4: Plasma levels of octreotide after an i.v. bolus injection of 0.025 mg in six rabbits. 
 
 
Figure 5: Plasma levels of octreotide after an i.m. bolus injection of 5 mg/kg of octreotide pamoate-loaded 
microspheres in eight rabbits. The inset shows the data collected during the first day of the experiment. 
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For i.v. bolus injection sufficient plasma levels of octreotide can only be achieved for a few 
hours. The release of octreotide from the microparticles leads to a triphasic absorption profile. 
During the initial phase about 5% of the drug is released. After a lag-phase the major part of 
the drug is released. A high interindividual variability especially in the magnitude of the 
absorption can be observed.  
Octreotide release from microspheres was studied under in vitro conditions [30]. After 27 
days more than 90% of the drug was released. The release profile depended on the ionic 
strength of the medium (Figure 6). In vivo a drug release for more than 40 days was observed 
(Figure 7). The data highlights the problem of “in vitro-in vivo-correlation”. A direct 
prediction of the in vivo release based on in vitro data is not possible in most cases. 
 
Figure 6: Cumulative in vitro release from octreotide loaded microspheres in acetate buffer with different salt 
concentrations. 
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Figure 7: Octreotide plasma levels of rabbits after i.m. application of 5 mg/kg octreotide loaded microspheres 
(three different formulations) 
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Summary: 
The objective of this study was to develop a new microencapsulation technique which uses an 
ionic liquid (IL) as one common solvent for a biodegradable polymer and a hydrophilic 
macromolecule. Biodegradable Polymers were sufficiently soluble in ILs, but hydrophilic 
macromolecules did not show sufficient solubility. Nevertheless the microencapsulation of 
bovine serum albumin (BSA) was possible via a phase separation technique, but 
encapsulation efficiencies were rather low. The size of the microparticles ranged between 25 - 
30 µm. Additionally, several dyes were tested for their solubility in ILs and the possibilities to 
encapsulate them as model compounds. Mean particle diameters, encapsulation efficiencies 
and release profiles for the dyes were determined. Several variations were applied to the 
microencapsulation technique in order to increase encapsulation efficiency for the dyes. A 
MTT assay was carried out to determine the cytotoxicity exemplary for one IL. Although we 
were not able to find an IL among the tested ones, which is capable of dissolving a 
biodegradable polymer and a hydrophilic macromolecule, this goal might be easily achievable 
with another IL. 
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Introduction: 
Ionic liquids (ILs) are defined as salts having melting points below 100°C. ILs which are 
liquid at room temperature are preferably used for most applications. Drawing the line 
between salts and ILs at 100°C is justified by their broadened application range below that 
temperature.  In contrast to molten salts, which are usually highly viscous and corrosive, ILs 
have low viscosities and are stable. They make up a new class of ionic solvents having 
remarkable characteristics. An IL is composed of at least 2 different molecules, an anion and a 
cation. They are nonflammable, thermally stable and nonvolatile. These properties make ILs 
very interesting as replacements for volatile organic compounds to achieve resource saving 
and environmentally harmless processes [1]. Furthermore, the use of ILs as solvents can lead 
to remarkable improvements in synthesis and catalysis [2, 3], liquid chromatography  [4, 5] or 
extraction processes [6-8]. 
Walden published the first IL in 1914, which was Ethylammoniumnitrate (Et-NH3+ NO3-) 
with a melting point at 12°C [9]. In 1948 Hurley und Wier were the first to use ILs as 
solvents, in this case for the electrodeposition of aluminium [10]. At the beginning ILs were 
primarily used in electrochemical processes [11]. These ILs were based on alkylpyridinium 
chloroaluminates A considerable drawback of these chlororaluminate based ILs was their 
need to protect them rigorously from moisture and other oxide impurities. In 1992 Wilkes et. 
al. introduced air and water stable imidazolim based ionic liquids, which are most commonly 
used until today [12]. Based on these results many new cation/anion combinations have been 
reported as ILs [13-15]. Even DNA is reported to have an IL form when combined with 
certain cations [16]. 
The synthesis of an IL is usually a two step reaction, where in the first step the cation is 
synthesized by quaternisation of an amine or phosphan and in a second step the desired anion 
is introduced [12, 17, 18]. The most common cations and possible anions are presented in 
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figure 1. Since different cation/anion combinations also have different chemical and physical 
properties, ILs are referred to as “designer solvents” [19-23]. 
 
Common cations: 
 Common anions: 
    -223-33-3-4-6-4-3-2-- NSOCFSOCFCOOCFAlClPFBFNONOBrCl
Figure 26: Most commonly used cations and anions of ionic liquids. 
 
 
The remarkable solvent properties of ILs could allow the development of a new 
microencapsulation technique for hydrophilic macromolecules like proteins or DNA. By 
discovering an IL which is capable of dissolving a biodegradable polymers and hydrophilic 
macromolecules a new phase separation process should be possible to encapsulate the drug 
substance with a minimum of degenerative forces. 
The goal of this study was to screen a selection of ILs for their abilities to dissolve 
biodegradable polymers, proteins or DNA and trying to relate their solubility behavior to 
other IL characteristics. After that, a new microencapsulation technique based on 
biodegradable polymers and ionic liquids for hydrophilic macromolecules was developed.  
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Materials and methods: 
Poly(DL-lactide) R202 (Mw=16 000), Poly(DL-lactide-co-glycolide) RG502 (Mw = 12 000), 
Poly(DL-lactide-co-glycolide) RG503 (Mw = 31 000) and Poly(DL-lactide-co-glycolide) 
RG505 (Mw = 80.000) were purchased from Boehringer Ingelheim (Ingelheim, Germany). 
Poly(DL-lactide-co-glycolide)-glucose (Mw = 55.200) was purchased from Novartis Pharma 
AG (Basel, Switzerland). 1-Butyl-3-methyl-imidazolium-methylsulfate  ([BMIM]CH3SO4) 
was purchased from „Solvent Innovation“ (Cologne, Germany) and 1-Butyl-3-methyl-
imidazolium-tetrafluoroborat ([BMIM]BF4) from Fluka Chemie GmbH (Buchs, Germany). 
All other ionic liquids from Table 1 were synthesized and provided by Novartis Pharma AG 
(Basel, Switzerland). All other reagents used were of analytical grade. 
 
 cation anion 
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CH3
+
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CF3SO3- 
CF3COO - 
[BMIM]BF4 
[BMIM]TfO 
[BMIM]TA 
[BMIM]CH3SO4 
[BMIM]PF6 
N NCH3
CH3
+
 
BF4- 
CF3SO3- 
CF3COO - 
CH3SO4 
PF6- 
[OMIM]Br 
N NCH3
CH3
+
 
Br - 
KIL6686   
KIL6684   
Table 1: Structures of tested ionic liquids. 
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Solubility of biodegradable polymers in ILs 
1 ml of the ionic liquids in Table 1 was added to 50 mg of the different biodegradable 
polymers and the mixture was homogenized by vortexing. After storing for 24 h under 
ambient conditions the tubes were centrifuged and the supernatant was isolated. Dissolved 
polymers were precipitated by the addition of water or water/ethanol mixtures for water 
immiscible ILs. The amount of precipitated polymer was determined gravimetrically. 
 
Solubility of hydrophilic macromolecules in ILs 
1 ml of the ionic liquids in Table 1 was added to 10 mg of the different proteins (Bovine 
serum albumin (BSA), Lysozyme, Cytochrome C, Insulin). After storing for 24 h under 
ambient conditions the tubes were centrifuged and the supernatant was isolated. Dissolved 
protein was precipitated by the addition of acetone. The amount of precipitated protein was 
determined gravimetrically. In addition, UV/Vis spectra of the supernatants were recorded 
using an UV/Vis spectrophotometer UV-160 (Shimadzu Corporation, Kyoto, Japan). 
1 ml of several ionic liquids from Table 1 was added to 3 mg of Herring testes DNA. After 
storing for 24 hours under ambient conditions the tubes were centrifuged and the supernatant 
was isolated. UV/Vis spectra of the supernatants were recorded using an UV/Vis 
spectrophotometer UV-160 (Shimadzu Corporation, Kyoto, Japan). 
4 µl of a pCMV-Luc solution (5mg / ml) was added to 1 ml of several ionic liquids from 
Table 1. After storing for 24 hours under ambient conditions the tubes were centrifuged and 
the supernatant was isolated. Agarose gel electrophoresis was used to check for dissolved 
plasmid DNA. 
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Size of microparticles 
The average size and the size distribution of the microparticles were determined using a 
Malven Mastersizer X (Malvern Instruments, UK). Particles were suspended in water and 
constantly agitated during measurements. 
 
Microencapsulation technique 
Microencapsulation was carried out in liquid paraffin with 2% of the emulsifier Brij 93 
(Uniqema Emmerich, Germany) as stabilizer for the emulsion of ionic liquids in liquid 
paraffin. Polyvinylalcohol Mowiol 3-83 (Hoechst AG Frankfurt am Main, Germany) was 
added to the aqueous phase for microparticle isolation.  
 
Morphology of microparticles 
Fragments of the nanofiber nonwovens were sputtered with gold in an argon atmosphere 
(0.3 mPa) using a sputter coater S-150 (Edwards Kniese & Co. GmbH, Marburg, Germany). 
Sputtering was carried out for each sample at 18 mA 2 times for 1 minute and after that 2 
times for 2 minutes. Images were taken with an SEM S-510 at 25 kV accelerating voltage 
(Hitachi Ltd. Corporation, Tokyo, Japan) using the Digital Imaging Scanning System 
(Version 5.4.12.1) purchased from point electronic GmbH, Halle (Saale), Germany. Images 
were analyzed with the Digital Image Processing System (Version 2.6.13.0) purchased from 
point electronic GmbH, Halle (Saale), Germany.  
 
Gel electrophoresis 
Native Page gel electrophoresis experiments were carried out using a Pharmacia LKB PHAST 
system (Pharmacia Biosciences, Uppsala, Sweden) and PhastGel separation media for Native 
PAGE (Pharmacia Biosciences, Uppsala, Sweden). The different protein solutions were 
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applied on the ready-to-use PhastGel 18-25 (Pharmacia Biosciences, Uppsala, Sweden) via a 
PhastSystem applicator comb. These special sample applicators ensure that identical volumes 
were put on the separation gel. PhastGel Native ready-to-use buffer strips were used for the 
separation process. After applying current, the proteins migrated through the gradient gel and 
were separated according to their size. A Coomassie staining was carried out for protein 
detection using PhastGel Blue R tablets.  
 
Release studies 
20 mg of the lyophilized microparticles were put in vials and 5 ml of PBS buffer solution pH 
7.4 was added. The vials were put into a Rotatherm that was thermostated at 37 °C and 
turning at 15 rpm. At several timepoints the vials were centrifuged and 1 ml of the buffer 
solution was removed and replaced by 1 ml of fresh buffer solution. The microparticles were 
resuspended and the vials put back into the Rotatherm. The amount of released substance was 
determined by UV/Vis-spectroscopy. 
 
Cytotoxicity of Ionic Liquids 
Cytotoxicity of [EMIM]TfO was tested using an MTT assay according to  [24]. L929 cells 
were seeded in 96-well microtiter plates at a density of 4200 cells per well and allowed to 
grow for 72 hours prior to the application of the IL solutions yielding concentrations ranging 
from 0.3 µg/ml to 10 mg/ml of the IL in cell media. After 4 hours of incubation, the medium 
was replaced with 200 μL fresh medium and 20 μL (3-(4,5-dimethylthiatol-2-yl)-2,5-diphenyl 
tetrazolium bromide) solution (MTT, Sigma, Seelze). After 4 hours, the unreacted dye was 
removed and 200 μL DMSO was added. The absorption was measured using the ELISA 
reader Titertek Plus MS 212 (ICN, Eschwege, Germany) at 570 nm, with a background 
correction at 690 nm. The relative cell viability (%) was related to control wells containing 
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cell culture medium without IL and was calculated by: absorption test x 100 % / absorption 
control. Data are presented as a mean of six measurements (± SD). 
 
Results and discussions: 
The objective of this study was to develop a new microencapsulation technique which uses an 
ionic liquid (IL) as one common solvent for polymer and drug. After emulsifying this solution 
in a lipophilic phase, the addition of water as phase separator to the emulsion should lead to 
precipitation of the polymer in the droplets of the inner phase of the emulsion and in addition 
to the encapsulation of the dissolved protein within the formed microparticles. For the 
development of this technique two prerequisites had to be accomplished: At first, sufficient 
solubility of a biodegradable polymer in the ILs and secondly, sufficient solubility of the 
desired drugs i.e. hydrophilic macromolecules in the ILs. Figure 2 shows the solubility of 
several biodegradable polymers in ILs.  
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Figure 27: Most commonly used cations and anions of ionic liquids. 
 
Some biodegradable polymers were sufficiently soluble in the ILs. The most promising 
among the tested ILs were composed of imidazolium cations with short alkyl chains in 
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combination with an anion with an acidic group. [BMIM]PF6 and KIL6684 showed also good 
solubility properties, but there immiscibility with water made them less suitable for our 
purposes. Promising ILs for further experiments were 1-ethyl-3-methyl-imidazolium-
tetrafluorosulfonate [EMIM]TfO, 1-ethyl-3-methyl-imidazolium-tetrafluoroacetate 
[EMIM]TA, 1-butyl-3-methyl-imidazolium-tetrafluorosulfonate [BMIM]TfO and 1-butyl-3-
methyl-imidazolium-tetrafluoroacetate [BMIM]TA. 
4 different proteins were tested for their solubility in the ILs: bovine serum albumin (BSA), 
lysozyme, cytochrome C and insulin. In all cases no precipitates were detectable. Only in one 
case (Cytochrome C in [EMIM]TA) an evidence of dissolved protein was found in the 
UV/Vis-spectrum of the supernatant, but the solubility of cytochrome C in [EMIM]TA was 
far below 1 mg/ml. This concentration was not sufficient for our microencapsulation 
experiments. The obtained results were in agreement with other publications like [25], which 
states that the “… dissolution of proteins … in ionic liquids is generally hindered by their 
insolubility.” In addition, the solubility of Herring testes DNA and of a plasmid DNA 
(pCMV-Luc) in the ILs was determined. Neither UV/Vis spectroscopy nor agarose gel 
electrophoresis were able to detect dissolved DNA.  
Since the desired drugs are not soluble in the ILs another approach was developed to 
encapsulate proteins using an ionic liquid as solvent. A solution of Poly(DL-lactide) R202 in 
[EMIM]TfO was emulsified in liquid paraffin. The emulsifier Brij 93 was added prior to the 
liquid paraffin to stabilize the emulsion. Stepwise addition of an aqueous BSA solution to the 
emulsion led to precipitation of the polymer and formation of microparticles. The resulting 
suspension was then added to a vial containing water. After centrifugation and removal of the 
supernatant the microparticles were isolated (Figure 3).  
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Figure 28: Processing steps of a microencapsulation technique using an ionic liquid. 
 
Three differently concentrated polymer solutions were used: 20 mg/ml, 30 mg/ml and 40 
mg/ml. After isolation of the microparticles by centrifugation they were resuspended and their 
size determined using a Malven Mastersizer X. The size of the microparticles was 
monomodally distributed. The following weighted averages of the volume distribution were 
found: for 20 mg/ml: D [4,3] = 32,04 µm, for 30 mg/ml: D [4,3] = 27,02 µm and for 40 
mg/ml: D [4,3] = 32,02 µm. The concentration of the polymer solution did not seem to have a 
great influence on the resulting particle size. 
SEM pictures of the microparticles were taken to evaluate the morphology of the 
microparticles (Figure 4). The SEM images showed microparticles with an average diameter 
of 20 - 30 µm. These results are in agreement with the data obtained by the above mentioned 
mastersizer measurements. The rough surface of the microparticles is the consequence of 
various washing steps which were needed to remove the ionic liquids. Using less washing 
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steps it was impossible to prepare SEM images of the particles due to remaining ILs. Since 
ILs cannot be vaporized, it is impossible to remove these substances in vacuum.  
 
Figure 29: SEM images of microparticles prepared with an ionic liquid. 
 
Successful encapsulation of BSA was demonstrated by dissolving the microparticles in 
methylene chloride, removing the supernatant and dissolving the remaining precipitant in 
water. The UV/Vis spectrum of the aqueous solution was similar to that of a BSA solution 
and native PAGE gel electrophoresis of this solution also proved that BSA was encapsulated 
for microparticles produced with [EMIM]TfO as solvent for the polymer. No BSA could be 
detected in the remaining precipitant of microparticles produced with [BMIM]TfO (Figure 5).  
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BSA     St.     [EMIM]TfO        St.      [BMIM]TfO      St. 
Figure 30: Native page gel electrophoresis of encapsulated BSA. 
 
Encapsulation efficiency was determined for four different polymer solutions. The amount of 
BSA in the first precipitate was relatively high (Table 2), but after additional washing of the 
microparticles with water only small amounts of BSA were detected (Table 3). Presumably 
the major part of BSA was not encapsulated in the microparticles but rather precipitated 
outside the polymer. 
 
c(polymer) 20 mg/ml 30 mg/ml 40 mg/ml 50 mg/ml 
EE 46.85 % 52.47 % 50.23 % 65.68 % 
loading 18,98 % 14,88 % 11,16 % 11,61 % 
 
Table 2: Encapsulation efficiency and loading determined in first precipitate. 
 
 
c(polymer) 20 mg/ml 30 mg/ml 40 mg/ml 50 mg/ml 
EE 6,00 % 4,23 % 8,25 % 8,61 % 
loading 2,82 % 1,34 % 1,95 % 1,65 % 
 
Table 3: Encapsulation efficiency and loading determined after additional washing steps. 
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Since proteins and DNA are not soluble in the tested ILs these substances could only be 
encapsulated with low encapsulation efficiency and loading. To prove that it was possible to 
encapsulate substances by dissolving them and the polymer in one IL, a dye as drug model 
should be encapsulated. The first step was to find a dye, which is soluble in the IL. The 
solubility of several dyes in [EMIM]TfO, [BMIM]TfO, [EMIM]TA and [BMIM]TA was 
determined and Rose Bengal and Reichardt’s dye demonstrated sufficient solubility. 
Reichardt’s dye and Poly(DL-lactide) R202 were dissolved in [EMIM]TfO and the above 
mentioned technique was used for the encapsulation of the dye. After dissolving of the 
microparticles in methylene chloride the encapsulation efficiency and loading should be 
determined by UV/Vis-spectroscopy, but the quantitative detection via UV/Vis was 
impossible due to strong interactions between the chromophores of Reichardt’s dye and the 
IL. It was possible to encapsulate Reichardts dye, but it was not possible to evaluate the 
amount of encapsulated dye.  
In a second approach, Rose Bengal and Poly(DL-lactide) R202 were dissolved in 
[EMIM]TfO and the above mentioned technique was used for the encapsulation of the dye. 
The amount of encapsulated Rose Bengal was too low to be detectable via UV/Vis-
spectroscopy.  Encapsulation efficiency and loading could not be determined. The major 
problem was that the dye dissolved in the added phase separator (water) before the polymer 
precipitated. After that, several experiments were carried out to increase loading and 
encapsulation efficiency by variation of the encapsulation method: The concentration of the 
polymer was varied in the range of 20 - 50 mg/ml, different phase separators (e.g. methanol, 
ethanol, isopropanol or other ionic liquids) were used and other polymers were dissolved in 
the IL (e.g. RG503, RG505). None of these variations led to an increase in encapsulation 
efficiency. But the addition of an aqueous solution of Rose Bengal (20 mg/ml) as phase 
separator to an IL solution of poly(DL-lactide) emulsified in liquid paraffin led to intensely 
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red colored particles. 3 different polymer solutions and 2 different Rose Bengal solutions 
were used to produce microparticles by the above mentioned method (Table 4).  
 
c(RB) / mg/ml c(R202) / mg/ml loading / w% EE / % 
10 20.52 4.92 23.97 
20 20.05 9.34 46.58 
10 30.59 5.19 16.96 
20 30.83 12.25 39.73 
10 40.16 5.62 13.99 
20 40.53 13.04 32.17 
 
Table 4: Loading and encapsulation efficiency of microparticles produced with 3 different polymer solutions 
and 2 different RB solutions. 
 
The encapsulation efficiency decreased with an increasing concentration of the polymer and 
increased with an increasing dye concentration. The size of the microparticles was 
monomodally distributed with weighted averages of the volume distribution ranging between 
30 and 55 µm. These microparticles were bigger than the ones prepared with BSA solution, 
which had diameters of ca. 30 µm.  
Figure 6 shows the release profile of Rose Bengal from the microparticles. After 3 hours 
100% of the dye was released from the microparticles. The release profile lets suggest, that 
only absorption of the dye to the surface of the microparticles occurred. Since Rose Bengal is 
likely to absorb on polymer surfaces probably only a very small amount of Rose Bengal was 
actually encapsulated inside the microparticles. 
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Figure 31: Release profile of Rose Bengal from microparticles prepared using an ionic liquid.  
 
Another dye should be chosen which shows sufficient solubility in the ILs, but is only slightly 
soluble in water and insoluble in liquid paraffin. The most important point was the solubility 
of the dye in water. The substance had to be at least slightly soluble in water to determine its 
release profile in an aqueous buffer solution. But the dye should not dissolve in the water, 
which was added as phase separator during the production of the microparticles. Neither 
should it be too lipophilic since then it would dissolve in the liquid paraffin. Furthermore, the 
ILs had made the search for an adequate dye more difficult, because they had a solubilizing 
effect in water. This meant a dye that was only slightly soluble in water dissolved easily by 
addition of small amounts of an IL. 17 different dyes were tested and among them thymol 
blue seemed to match the above mentioned properties best. Encapsulation of thymol blue was 
carried out by dissolving 50 mg R202 and 8 mg TB in 1 ml [EMIM]TfO, emulsification of 
this solution in liquid paraffin with 1 % Brij 93 and the addition of water as phase separator. 
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The loading of the microparticles was very low with values less than 1%. Again the dye was 
dissolved in the phase separator supported by the solubilizing properties of the ILs during the 
preparation of the microparticles. 
Although the ILs have to be removed completely from the prepared microparticles, these 
substances should feature a low cytotoxicity to be suitable for the preparation of parenteral 
dosage forms. An MTT assay was carried out to determine the cytotoxicity of [EMIM]TfO. 
The tested concentrations ranged between 0.3 µg/ml and 10 mg/ml. For concentrations below 
5 mg/ml only slight influence on cell viability could be detected (Figure 7). It is most unlikely 
that the amount of remaining IL in the microparticles will lead to such high concentrations of 
ILs in vivo. This leads to the conclusion that ILs are suitable solvents for the production of 
microparticles. 
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Figure 32: Cytotoxicity of the ionic liquid [EMIM]TfO. 
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Conclusion: 
We demonstrated that biodegradable Polymers were sufficiently soluble in ILs, but 
hydrophilic macromolecules did not show sufficient solubility. Nevertheless the 
microencapsulation of BSA was possible via a modified technique but showed very low 
encapsulation efficiency. The size of the microparticles ranged between 25 - 30 µm but the 
morphology remained unclear, since several washing steps, which influenced the morphology 
of the microparticles, were needed to prepare them for SEM imaging. Reichardts dye was 
soluble in ILs and was encapsulated, but could not be quantified via UV/Vis-spectroscopy. 
Rose Bengal was slightly soluble in ILs but dissolved in the added phase separator during 
preparation of microparticles, which led to low encapsulation efficiencies. The release profile 
lets suggest, that only absorption of the dye on the surface of the mircoparticles occurred. 
Thymol blue was soluble in ILs and only slightly soluble in water, but as a result of the 
solubilizing effect of the ILs the major part also dissolved in the added phase separator during 
preparation of the microparticles. The low cytotoxicity of [EMIM]TfO proved that ILs are 
suitable solvents for the preparation of microparticles. Although we were not able to find an 
IL among the tested ones, which is capable of dissolving a biodegradable polymer and a 
hydrophilic macromolecule, this goal might be easily achievable with another IL. J.D. 
Holbrey und K.R. Seddon assumed that there are about 1018 possible cation / anion 
combinations which yield an IL [1] and it is most likely that one amongst them has the 
suitable solution properties for our purposes. 
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Summary and Perspectives 
Summary and Perspectives: 
This thesis describes two novel technologies for the encapsulation of proteins in 
biodegradable polymers. Protein loaded nanofiber nonwovens and microparticles were 
manufactured and characterized regarding their suitability as drug delivery devices. 
Chapter 1 gave a detailed overview on the current status of electrospinning as a technique for 
the generation of nanofibrous scaffolds. Basic principles of electrospinning as well as several 
modification of the standard method were discussed and the applications of electrospun 
scaffolds in the biomedical field were elucidated. 
Several biodegradable polymers (Poly(L-lactide) (PLLA) Resomer L210, poly(lactide-co-
glycolide) (PLGA) Resomer RG858 and  Poly(ethylene carbonate) (PEC)) were investigated 
in Chapter 2 for their application in electrospinning of emulsions. Suitable process 
parameters were determined for all polymers to generate protein loaded nanofiber nonwovens 
(NNs). The resulting NNs were examined regarding their morphology and regarding their 
protein release profile. PEC formed the most uniform fibers with diameters of 1 to 5 µm. 
PLLA and PLGA formed less uniform fibers but with smaller diameters of 0.3 to 1 µm. PEC 
and PLGA NNs showed only burst release of the incorporated protein and no further release 
within 2 weeks. PLLA NNs released the protein very slowly and in a controlled manner. Due 
to the swelling of PLGA and PEC almost all fibers had lost their individuality after incubation 
in buffer solution. The morphology of PLLA NNs was more or less unchanged after the 
release study. PLLA NNs exhibited the most promising characteristics and hence were chosen 
for further studies. 
In Chapter 3 protein loaded PLLA NNs were electrospun from differently concentrated 
solutions. The NNs featured a superhydrophobic surface and it was demonstrated, that the 
wettability of these scaffolds was the major factor influencing the protein release. Although 
TEM images showed that the major part of the protein was most likely located between the 
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fibers and not encapsulated inside the fibers, the protein was released very slowly from the 
PLLA NNs. Only 20 – 30% of the protein was released within one month. The addition of 
hydrophilic polymers like poly(ethylene imine) (PEI) or poly(L-lysine) (PLL) to the aqueous 
phase of the electrospinning emulsion yielded NNs composed of polymer blends of PLLA 
and the respective hydrophilic polymer. It was demonstrated that the amount of added 
hydrophilic polymer had a significant effect on the release profile. A higher amount of 
hydrophilic polymer led to a faster release of the protein and gave us the opportunity to tailor 
the release profile of these NNs. Compositions of 5 or 10% PLL or PEI and 95 or 90% PLLA 
respectively, showed the most promising release profiles. Further screening of compositions 
ranging from 1 to 10% of hydrophilic polymers should be investigated to find the most 
appropriate release pattern. 
Whether NNs electrospun from emulsions are suitable scaffolds for their application in tissue 
engineering was determined in Chapter 4. The prepared NNs met all requirements for a 
tissue engineering scaffold: Mean fiber diameters of the scaffolds were very similar to fibrous 
protein structures of the extracellular matrix (ECM), meaning these scaffolds could physically 
resemble the ECM. Cell adhesion, cell proliferation and cell spreading on all NNs were at 
least as good as on a glass surface. For a composition of 5% PLL and 95% PLLA these values 
were even significantly higher. NNs took up water and swelled in the cell medium. The extent 
of swelling depended on the amount of hydrophilic polymer with a higher fraction leading to 
increased swelling. Cells still adhered to the fibers and were able to proliferate in all three 
dimensions. There were no significant differences in cell viability for cells grown on NNs 
compared to the cell viability on a glass surface. These results strongly suggest a huge 
potential of these nanofiber nonwovens for their application in tissue engineering. 
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Chapter 5 gave an overview on microencapsulation focusing on phase separation and 
coacervation techniques. The development of these techniques and its application in the 
pharmaceutical industry were elucidated. 
The development of a new microencapsulation technique which utilizes an ionic liquid as one 
common solvent for a biodegradable polymer and a hydrophilic macromolecule was 
presented in Chapter 6. Some of the tested ionic liquids were good solvents for 
biodegradable polymers, but none of them was able to dissolve hydrophilic macromolecules. 
Even though there was no suitable ionic liquid among the tested compounds, the probability 
of finding a suitable ionic liquid is very high, since there are almost countless possibilities for 
the synthesis of different ionic liquids. Nevertheless the feasibility of encapsulating BSA via 
an emulsion based phase separation technique was demonstrated. 
Generally, it can be stated that the presented novel techniques for the encapsulation of 
proteins in biodegradable polymers demonstrated their huge potential for the preparation of 
drug delivery devices. Protein loaded nanofiber nonwovens exhibited very promising 
properties for their use as tissue engineering scaffolds and will definitely find application in 
this field. Screening the huge library of ionic liquids to find a compound with suitable solvent 
properties will be a difficult task, but the discovery of an appropriate ionic liquid will be a 
powerful tool for the encapsulation of proteins in microparticles 
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Zusammenfassung und Ausblick 
Zusammenfassung und Ausblick: 
Diese Doktorarbeit beschreibt zwei neuartige Technologien für die Verkapselung von 
Proteinen in bioabbaubaren Polymeren. Nanofasermatten und Mikropartikel, die mit 
Proteinen beladen waren, wurden hergestellt und auf ihre Anwendbarkeit als Systeme für 
kontrollierte Wirkstofffreigabe getestet. 
Kapitel 1 gibt einen detaillierten Überblick über den aktuellen Stand über die Anwendung des 
Elektrospinnens zur Herstellung von Nanofasermatten. Sowohl grundlegende Prinzipien des 
Elektrospinnens als auch einige Modifikationen der Standardmethode werden diskutiert und 
die Anwendung von elektrogesponnen Nanofasermatten im Bereich der Biomedizin werden 
erläutert. 
Mehrere bioabbaubare Polymere (Polymilchsäure (PLLA) Resomer L210, Polylaktid-co-
glykolid (PLGA) Resomer RG858 und  Polyethylencarbonat (PEC)) werden in Kapitel 2 auf 
ihre Anwendbarkeit für das Elektrospinnen von Emulsionen untersucht. Geeignete 
Prozessparameter wurden für alle Polymere ermittelt, um mit Protein beladene 
Nanofasermatten (NNs) herzustellen. Die erhaltenen NNs wurden bezüglich ihrer 
Morphologie und ihres Protein Freisetzungsprofils charakterisiert. PEC bildete die 
gleichmäßigsten Fasern mit Durchmessern von 1 – 5 µm. PLLA und PLGA Fasern waren 
weniger gleichmäßig, zeigten aber kleinere Durchmesser von 0,3 – 1 µm. PEC und PLGA 
NNs zeigten nur eine schnelle initiale Proteinfreisetzung und keine weitere Freisetzung 
während der folgenden 2 Wochen. PLLA NNs gaben das Protein sehr langsam und 
gleichmäßig ab. Aufgrund der Quellung von PLGA und PEC hatten fast alle Fasern ihre 
Individualität verloren, nachdem sie in Pufferlösung inkubiert worden waren. Die 
Morphologie der PLLA NNs war mehr oder weniger unverändert nach der Freisetzungsstudie. 
PLLA NNs zeigten die verheißungsvollsten Eigenschaften und wurden daher für 
weitergehende Versuche ausgewählt. 
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In Kapitel 3 wurden mit Protein beladene NNs aus unterschiedlich konzentrierten 
Polymerlösungen electrogesponnen. Die NNs hatten eine superhydrophobe Oberfläche und es 
konnte gezeigt werden, dass die geringe Benetzbarkeit dieser Fasermatten den größten 
Einfluss auf die Proteinfreisetzung hat. Obwohl TEM Bilder gezeigt hatten, dass ein großer 
Teil des Proteins wahrscheinlich zwischen den Fasern vorliegt und nicht in ihnen verkapselt 
ist, wurde das Protein nur sehr langsam aus den NNs freigesetzt. Nur 20 – 30% des Proteins 
wurde innerhalb eines Monats freigesetzt. Die Zugabe von hydrophilen Polymeren wie 
Polyethylenimin (PEI) oder Poly-L-lysin (PLL) zur wässrigen Phase der Electrospinning-
emulsion ergab NNs die aus einer Polymermischung von PLLA und dem jeweiligen 
hydrophilen Polymer bestanden. Es konnte gezeigt werden, dass die Menge an zugegebenem 
hydrophilem Polymer einen signifikanten Einfluss auf das Freisetzungsprofil hat. Ein 
größerer Anteil an hydrophilem Polymer führte zu einer schnelleren Freisetzung des Proteins 
und ermöglichte dadurch, das Freisetzungsprofil der NNs entsprechend einzustellen. 
Zusammensetzungen aus 5 oder 10% PLL oder PEI und entsprechend 95 oder 90% PLLA 
zeigte die aussichtsreichsten Freisetzungsprofile. Eine weitere Abklärung der 
Freisetzungsprofile von Zusammensetzungen mit 1 bis 10% an hydrophilem Polymer sollten 
noch genauer untersucht werden, um das am besten geeignete Freisetzungsprofil zu finden. 
Ob aus Emulsionen gesponnene NNs geeignete Substrate für eine Anwendung als Tissue 
engineering scaffold sind wird in Kapitel 4 untersucht. Die hergestellten NNs erfüllten alle 
Voraussetzungen für ein Tissue engineering scaffold: der mittlere Faserdurchmesser der NNs 
war den fibrösen Proteinstrukturen der extrazellulären Matrix (ECM) sehr ähnlich; dies 
bedeutet, das diese NNs die ECM physikalisch imitieren können. Zelladhäsion, 
Zellproliferation und die Zellspreitung auf den NNs war mindestens genauso gut wie auf einer 
Glasoberfläche. Für eine Zusammensatzung von 5% PLL und 95% PLLA waren diese Werte 
sogar signifikant erhöht. Die NNs nahmen Wassser auf und quollen im Zellmedium. Das 
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Ausmaß der Quellung war abhängig von der Menge an hydrophilem Polymer und ein höherer 
Anteil führte zu einer erhöhten Quellung. Die Zellen adherierten weiterhin an den Fasern und 
bekamen dadurch die Möglichkeit in alle drei Dimensionen zu proliferieren. Es gab keine 
signifikanten Unterschiede in der Zellviabilität zwischen Zellen, die auf NNs gewachsen 
waren verglichen mit Zellen, die auf einer Glasoberfläche gewachsen waren. Diese 
Ergebnisse zeigen das große Potential dieser NNs für ihre Anwendung im Bereich des Tissue 
engineerings. 
Kapitel 5 gibt einen Überblick über die Mikroverkapselung mit dem Fokus auf 
Phasenseparations- und Koazervationsverfahren. Die Entwicklung dieser Techniken und ihre 
Anwendungen in der pharmazeutischen Industrie werden erläutert. 
Die Entwicklung eines neuen Mikroverkapselungsverfahrens, bei dem eine ionische 
Flüssigkeit als gemeinsames Lösungsmittel sowohl für ein bioabbaubares Polymer als auch 
für ein hydrophiles Makromolekül verwendet wird, wird in Kapitel 6 beschrieben. Einige der 
getesteten ionischen Flüssigkeiten waren gute Lösungsmittel für bioabbaubare Polymere, aber 
keine von ihnen war in der Lage hydrophile Makromoleküle zu lösen. Obwohl unter den 
getesteten ionischen Flüssigkeiten keine geeignete Verbindung war, ist die 
Wahrscheinlichkeit eine geeignete Substanz zu finden sehr hoch, da es beinahe unzählige 
Möglichkeiten für die Synthese unterschiedlicher ionischer Flüssigkeiten gibt. Trotzdem 
konnte gezeigt werden, dass es möglich ist BSA über eine emulsionsbasierte 
Phasenseparationstechnik zu verkapseln. 
Im Allgemeinen kann gesagt werden, dass die hier präsentierten neuartigen Methoden zur 
Verkapselung von Proteinen in bioabbaubaren Polymeren ihr großes Potential zur Herstellung 
von Systemen für kontrollierte Wirkstofffreigabe gezeigt haben. Mit Proteinen beladene 
Nanofasermatten zeigten sehr vielversprechende Eigenschaften für ihre Anwendung als 
Tissue engineering scaffolds und werden mit Sicherheit in diesem Feld eine Anwendung 
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finden. Das Durchsuchen der riesigen Auswahl an ionischen Flüssigkeiten, um eine 
Verbindung mit geeigneten Lösemitteleigenschaften zu finden, mag eine schwierige Aufgabe 
sein, allerdings hätte man mit der Entdeckung einer geeigneten Substanz ein mächtiges 
Werkzeug für die Verkapselung von Proteinen zur Hand. 
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